Download the Monday Daily - American Association for Clinical ...
Download the Monday Daily - American Association for Clinical ...
Download the Monday Daily - American Association for Clinical ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
president ’s Welcome<br />
PreParing <strong>for</strong><br />
<strong>the</strong> future Welcome to <strong>the</strong><br />
world’s premier<br />
international<br />
event <strong>for</strong> clinical<br />
laboratorians, <strong>the</strong><br />
2008 AACC Annual<br />
Meeting and<br />
Larry Broussard, PhD<br />
<strong>Clinical</strong> Lab Expo.<br />
AACC is proud<br />
to host this meeting in Washington,<br />
D.C., capital of <strong>the</strong> United States<br />
and home of our national office. I<br />
extend a warm welcome to everyone,<br />
especially ASCLS members, who are<br />
holding <strong>the</strong>ir annual meeting with<br />
us this week. I also want to recognize<br />
<strong>the</strong> ef<strong>for</strong>ts of <strong>the</strong> many o<strong>the</strong>r societies,<br />
too numerous to list here, that<br />
participated in putting toge<strong>the</strong>r this<br />
week’s program.<br />
Education, networking, and<br />
exposition are <strong>the</strong> three pillars of<br />
<strong>the</strong> 2008 Annual Meeting. The 2008<br />
Annual Meeting Organizing Committee,<br />
led by Ann Gronowski, PhD,<br />
deserves special congratulations <strong>for</strong><br />
developing a scientific program that<br />
disseminates <strong>the</strong> latest in<strong>for</strong>mation<br />
on developments in laboratory<br />
medicine, including presentations<br />
on areas such as pharmacogenomics,<br />
autoimmune disease, toxicology,<br />
molecular diagnostics, cancer, and<br />
much more.<br />
This meeting provides unparalleled<br />
opportunities to spend time<br />
with your peers from around <strong>the</strong><br />
world. In addition to <strong>the</strong> many<br />
educational sessions, special interest<br />
group meetings and social events<br />
abound, giving every attendee <strong>the</strong><br />
opportunity to spend time with familiar<br />
colleagues, as well as meet new<br />
colleagues with common interests.<br />
I know from my own personal experience<br />
that AACC offers so much<br />
more than just scientific sessions.<br />
Take this opportunity to network<br />
and build relationships that will<br />
maintain <strong>the</strong>ir value after you return<br />
home. I have made many lifelong<br />
friends at this annual event, and it is<br />
wonderful to see <strong>the</strong>m every year.<br />
The <strong>Clinical</strong> Lab Expo, <strong>the</strong> largest<br />
event of its kind, is <strong>the</strong> place to see<br />
all <strong>the</strong> newest products and services<br />
<strong>for</strong> clinical labs. I extend a warm<br />
welcome to all our colleagues from<br />
<strong>the</strong> many companies, both large and<br />
small, that are present at this year’s<br />
exposition. Companies work hard all<br />
year to debut <strong>the</strong>ir newest innovations<br />
at AACC, and I applaud <strong>the</strong>m<br />
<strong>for</strong> helping advance <strong>the</strong> field of laboratory<br />
medicine. Many attendees tell<br />
me that <strong>the</strong>y return to <strong>the</strong>ir lab each<br />
year armed with <strong>the</strong> in<strong>for</strong>mation<br />
<strong>the</strong>y need to make critical purchasing<br />
decisions <strong>for</strong> <strong>the</strong>ir organizations.<br />
As you network with colleagues<br />
and peers from around <strong>the</strong> world<br />
this week, I think you will gain a<br />
greater appreciation <strong>for</strong> <strong>the</strong> global<br />
nature of clinical chemistry today. I<br />
hope you enjoy your week in Washington<br />
and that you leave with in<strong>for</strong>mation<br />
that will help you advance<br />
<strong>the</strong> practice and profession of clinical<br />
laboratory science and its application<br />
to healthcare in your workplace.<br />
T h e M o n D a y Co n v e n T i o n Da i Ly<br />
<strong>Clinical</strong><br />
Laboratory<br />
News<br />
Is Warfarin Pharmacogenomic<br />
Testing Ready <strong>for</strong> Prime Time?<br />
Today’s Debate to Focus on Implementation Issues<br />
By DeBorah Levenson<br />
in recent years, personalized medicine has become <strong>the</strong> subject<br />
of much hype in newspapers and magazines, although it<br />
has yet to become a part of routine healthcare. But with an<br />
August 2007 update to <strong>the</strong> warfarin package insert, FDA may<br />
have nudged patient care closer to an era in which genetic in<strong>for</strong>mation<br />
helps tailor care <strong>for</strong> millions. The updated insert makes<br />
clinicians aware that patients with certain variants of <strong>the</strong> CYP2C9<br />
and VKORC1 genes probably need lower initial doses. But despite<br />
FDA’s suggestion that warfarin pharmacogenomic assays might aid<br />
dosing, use of such tests remains controversial.<br />
While most experts on pharmacogenomic testing say it holds<br />
great potential <strong>for</strong> patient care, <strong>the</strong>y disagree about whe<strong>the</strong>r now<br />
is <strong>the</strong> time to implement it widely. “Everyone says personalized<br />
medicine is <strong>the</strong> wave of <strong>the</strong> future, but <strong>the</strong> question is really <strong>the</strong><br />
rate at which it is rolled out,” said Michael Hallworth, FRCPath,<br />
Consultant <strong>Clinical</strong> Scientist at Royal Shrewsbury Hospital in<br />
Shropshire, U.K. “Warfarin genomic testing is like <strong>the</strong> poster child<br />
<strong>for</strong> personalized medicine because it addresses diseases that affect<br />
millions. It’s a paradigm <strong>for</strong> widespread adoption of genomic testing.” Hallworth is moderator of a debate titled<br />
“Warfarin Pharmacogenomic Testing: Now Ready <strong>for</strong> Prime Time?” scheduled <strong>for</strong> 10:30 a.m. in room 150AB<br />
of <strong>the</strong> Walter E. Washington Convention Center.<br />
See Warfarin debate, continued on page 8<br />
A Global Perspective on Healthcare<br />
Conference Program Puts Spotlight on Needs of<br />
Developing World<br />
By BiLL MaLone<br />
last year Paul Yager, PhD, Professor and Acting Chair of <strong>the</strong> Department of Bioengineering at <strong>the</strong><br />
University of Washington, Seattle, made a trip to South Africa to attend a meeting <strong>for</strong> principal investigators<br />
of <strong>the</strong> Bill & Melinda Gates Foundation’s Grand Challenges in Global Health initiative.<br />
During his stay, Yager visited a township with an HIV infection rate of 29% and very hight rate of TB<br />
infection. While walking around this very poor area, he noticed a lot of <strong>the</strong> locals using cell phones.<br />
“So I whipped out my cell phone—from Seattle—flipped it open, and I got five bars. And <strong>the</strong>n I went and took a<br />
picture with my phone, and that picture ended up back in my hotel on my laptop be<strong>for</strong>e I got <strong>the</strong>re. So I asked a<br />
guy, ‘Does everyone have cell phones here? And he said ‘Oh, yes, everyone.’ And he took a look at my phone and<br />
said, ‘And most of ours are much nicer than yours.’”<br />
Yager wasn’t visiting South Africa to study cell phones—he’s developing a rugged POC device <strong>for</strong> infectious<br />
diseases—but <strong>the</strong> ubiquity of cell phones <strong>the</strong>re represents a solid example of how certain technologies have<br />
been able to ‘leapfrog’ older technologies and penetrate regions of <strong>the</strong> world that are remote, very poor, and<br />
experiencing severe health problems—areas referred to as low-resource settings. “You look at that situation and<br />
say, ‘If that technology can make it, how can we piggyback on that existing cell phone technology, <strong>for</strong> example,<br />
and use <strong>the</strong> strength of that in order to bring in relatively sophisticated diagnostic equipment?’ ” Yager said. He is<br />
one of three speakers at today’s afternoon symposium “Diagnostics <strong>for</strong> <strong>the</strong> Developing World,” in room 146C.<br />
Bala Manian, PhD, of RealMetrix (San Carlos, Calif.) and Hans-Georg Batz, PhD, of ArteBioConsulting<br />
(Tutzing, Germany) will also be speaking.<br />
The symposium is one of several events at <strong>the</strong> 2008 AACC Annual Meeting that fall under <strong>the</strong> rubric<br />
of global health, a subject that has interested Ann Gronowski, PhD, Chair of <strong>the</strong> 2008 Annual Meeting<br />
See Global healthcare, continued on page 46<br />
The auThoriTaTive<br />
source <strong>for</strong> The<br />
clinical laboraTorian<br />
july 28, 2008<br />
special ediTion<br />
www.aacc.org<br />
in This issue<br />
3<br />
6<br />
8<br />
9<br />
10<br />
Plenary Speakers:<br />
Vagelos, Blackburn<br />
Industry Workshops<br />
Cokie Roberts Speaks at<br />
Special Event Today<br />
AACC Thanks<br />
Corporate Sponsors<br />
Congratulations to <strong>the</strong><br />
2008 AACC Award Winners<br />
12 Student<br />
Oral Presentations<br />
NACB Honors<br />
Award Winners<br />
14<br />
14<br />
20<br />
NACB Distinguished<br />
Abstract Awards<br />
2008 New Product Review
<strong>Clinical</strong><br />
Laboratory<br />
News<br />
ediTorial sTaff<br />
editor—Nancy Sasavage, PhD<br />
senior editors—John Bell, Phil Kibak,<br />
Deborah Levenson<br />
Managing editor—Bill Malone<br />
business sTaff<br />
v.p. strategic initiatives and<br />
business development—Joseph Perrone, ScD<br />
circulation Manager—Mickie Napoleoni<br />
board of ediTors<br />
chair—Jack A. Maggiore, PhD,<br />
BioSafe Laboratories, Chicago, Ill.<br />
Members—Nikola Baumann, PhD,<br />
University of Illinois Medical Center at<br />
Chicago, Chicago, Ill.<br />
Thomas Daly, MD,<br />
Eli Lilly and Company, Indianapolis, Ind.<br />
David Grenache, PhD, University of Utah and<br />
ARUP Laboratories, Salt Lake City, Utah.<br />
Elia M. Mears, MS, MT (ASCP), SM<br />
Chabert Medical Center, Houma, La.<br />
Alan T. Remaley, MD, PhD,<br />
National Institutes of Health, Be<strong>the</strong>sda, Md.<br />
aacc officers<br />
president—Larry A. Broussard, PhD<br />
president-elect—Barbara Goldsmith, PhD<br />
Treasurer—Ann Gronowski, PhD<br />
secretary—Anthony W. Butch, PhD<br />
past-president—Gary L. Myers, PhD<br />
adverTisinG sales<br />
Scherago International, Inc.<br />
525 Washington Blvd, Ste. 3310<br />
Jersey City, NJ 07310<br />
Phone: (201) 653-4777, Fax: (201) 653-5705<br />
E-mail: aacc@scherago.com<br />
president—H.L. Burklund<br />
vice president sales—Jack Ryan<br />
Marketing director—Steven A. Hamburger<br />
Traffic Manager—Roni Jackling<br />
subscripTions<br />
<strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Clinical</strong> Chemistry, Inc.<br />
1850 K Street, NW, Suite 625<br />
Washington, DC 20006<br />
Phone: (202) 857-0717 or (800) 892-1400<br />
Fax: (202) 887-5093<br />
E-mail: custserv@aacc.org<br />
Subscriptions to <strong>Clinical</strong> Laboratory News are<br />
free to qualified laboratory professionals in<br />
<strong>the</strong> United States. AACC members outside<br />
<strong>the</strong> U.S. pay $72 <strong>for</strong> postage. The subscription<br />
price <strong>for</strong> those who do not qualify <strong>for</strong> a<br />
free subscription is $72/year in <strong>the</strong> U.S. and<br />
$109/year outside <strong>the</strong> U.S. Back issues may be<br />
ordered <strong>for</strong> $10 as available. For more in<strong>for</strong>mation,<br />
contact <strong>the</strong> AACC Customer Service<br />
Department at (800) 892-1400 or<br />
(202) 857-0717 or custserv@aacc.org.<br />
ediTorial correspondence<br />
Nancy Sasavage, PhD, Editor<br />
<strong>Clinical</strong> Laboratory News<br />
1850 K Street, NW, Suite 625<br />
Washington, DC 20006<br />
Phone: (202) 835-8725 or (800) 892-1400<br />
Fax: (202) 835-8725<br />
E-mail: nsasavage@aacc.org<br />
Contents copyright © 2008 by <strong>the</strong> <strong>American</strong><br />
<strong>Association</strong> <strong>for</strong> <strong>Clinical</strong> Chemistry, Inc.,<br />
except as noted. Printed in <strong>the</strong> U.S.A.<br />
<strong>Clinical</strong> Laboratory News (ISSN 0161-9640)<br />
is <strong>the</strong> authoritative source <strong>for</strong> timely analysis<br />
of issues and trends affecting clinical<br />
laboratories, clinical laboratorians, and <strong>the</strong><br />
practice of clinical laboratory science.<br />
P l e n a ry SPeaker SP ot l i g h t<br />
sunday’s plenary speaker,<br />
p. roy vagelos, Md<br />
P. Roy Vagelos, MD, is Chairman of Regeneron<br />
Pharmaceuticals, Inc. (Tarrytown,<br />
N.Y.) and Theravance, Inc. (South San<br />
Francisco, Calif.). In addition to his business<br />
activities, he is an active alumnus of<br />
Columbia University School of Medicine.<br />
Dr. Vagelos chairs a board of visitors at<br />
Columbia that advises <strong>the</strong> Dean on strategies<br />
and issues. He joined pharmaceutical<br />
giant Merck & Co. in 1975 as Senior Vice<br />
President of Research and became President<br />
of its research division one year later.<br />
In 1982 he became Senior Vice President of<br />
<strong>the</strong> company, and in 1984 he was elected to<br />
<strong>the</strong> Board of Directors and became Merck’s<br />
Executive Vice President. He served as<br />
Chairman from 1986-1994.<br />
<strong>Monday</strong>’s plenary speaker,<br />
elizabeth h. blackburn, phd<br />
Elizabeth Blackburn, PhD, in 1985 discovered<br />
telomerase, an enzyme associated with<br />
uncontrolled proliferation of cells. Seen in<br />
as many as 90% of all cancers, telomerase<br />
is considered by many to be an ideal target<br />
<strong>for</strong> developing broadly effective anti-cancer<br />
drugs. First identified in human tumors in<br />
<strong>the</strong> mid-1990s, telomerase replenishes <strong>the</strong><br />
ends of eukaryotic chromosomes, known<br />
as telomeres, in a process that guards against<br />
<strong>the</strong> scrambling of genetic in<strong>for</strong>mation.<br />
The UCSF professor’s lab also discovered<br />
that chemical inhibitors of telomerase<br />
cause human cell telomeres to shorten and<br />
that certain mutant telomerases impair<br />
cell division. Blackburn and her team are<br />
now applying <strong>the</strong>se finding to an anticancer<br />
strategy in human breast, prostate, and<br />
bladder cancer cells.<br />
P. Roy Vagelos, MD<br />
The changing pharmaceutical industry<br />
sunday, july 27, 5:00 p.m.–6:30 p.m.<br />
current position: Chairman, Regeneron Pharmaceuticals, Inc., and<br />
Theravance, Inc.<br />
education: Columbia University, New York, N.Y., MD; Internship and<br />
residency at Massachusetts General Hospital, Boston, Mass.<br />
previous positions: Senior Surgeon and Head of Section of Biochemistry,<br />
National Heart Institute, National Institutes of Health (Be<strong>the</strong>sda, Md.); Chair,<br />
Department of Biological Chemistry, and Director, Division of Biology and<br />
Biochemistry, Washington University School of Medicine (St. Louis, Mo.);<br />
Chief Executive Officer, Merck & Co. (Whitehouse Station, N.J.).<br />
Dr. Vangelos’s contributions have earned<br />
him numerous awards and honors. In 1972<br />
he was elected to <strong>the</strong> National Academy of<br />
Sciences and <strong>the</strong> <strong>American</strong> Academy of<br />
Arts and Sciences. O<strong>the</strong>r awards he has received<br />
include: <strong>the</strong> Lawrence A. Wien Prize<br />
in Social Responsibility from Columbia<br />
University, <strong>the</strong> C. Walter Nichols Award<br />
from <strong>the</strong> Stern School of Business of New<br />
York University, <strong>the</strong> National Academy of<br />
Science Award <strong>for</strong> Chemistry in Service to<br />
Society, <strong>the</strong> Prince Mahidol Award from<br />
<strong>the</strong> Prince Mahidol Award Foundation<br />
(Bangkok,Thailand), <strong>the</strong> Othmer Gold<br />
Medal from <strong>the</strong> Chemical Heritage Foundation,<br />
and <strong>the</strong> Bower Award in Business<br />
Leadership from <strong>the</strong> Franklin Institute.<br />
Elizabeth H. Blackburn, PhD<br />
Telomerase and Telomere biology<br />
<strong>Monday</strong>, july 21, 8:45 p.m.–10:15 a.m.<br />
In addition, he has received 14 honorary<br />
degrees.<br />
In his plenary talk, Dr. Vagelos will address<br />
<strong>the</strong> ups and downs of <strong>the</strong> pharmaceutical<br />
industry, from its “golden age” of <strong>the</strong><br />
1970s, 1980s, and 1990s, to being an industry<br />
“in a funk.” During its golden age, <strong>the</strong><br />
industry was extolled <strong>for</strong> its accomplishments<br />
in increasing lifespan and improving<br />
overall quality of life. But results of a 2004<br />
Harris Poll indicated that people regarded<br />
<strong>the</strong> industry negatively, putting it on a par<br />
with tobacco and oil companies. Dr. Vagelos<br />
believes <strong>the</strong> industry is going through a<br />
pause as it ushers in an important new age<br />
of discovery in functional genomics and<br />
personalized medicine. cln<br />
current position: Morris Herzstein Professor of Biology and Physiology,<br />
Department of Biochemistry and Biophysics, University of Cali<strong>for</strong>nia,<br />
San Francisco; and Non-Resident Fellow, Salk Institute<br />
education: PhD, University of Cambridge, 1975<br />
previous positions: Department Chair, Department of Microbiology and<br />
Immunology at University of Cali<strong>for</strong>nia, San Francisco (UCSF); Faculty<br />
Member, Department of Molecular Biology, University of Cali<strong>for</strong>nia at<br />
Berkeley<br />
Blackburn was previously Chair of <strong>the</strong><br />
Department of Microbiology and Immunology<br />
at <strong>the</strong> University of Cali<strong>for</strong>nia<br />
San Francisco and is currently a faculty<br />
member in UCSF’s Department of Biochemistry<br />
and Physics. Prior to her work<br />
at UCSF, she was a faculty member in <strong>the</strong><br />
Department of Molecular Biology at <strong>the</strong><br />
University of Cali<strong>for</strong>nia at Berkeley. She<br />
is also a Non-Resident Fellow of <strong>the</strong> Salk<br />
Institute.<br />
Blackburn is a member of <strong>the</strong> Institute<br />
of Medicine and is an elected Fellow of <strong>the</strong><br />
<strong>American</strong> Academy of Arts and Sciences,<br />
<strong>the</strong> Royal Society of London, <strong>the</strong> <strong>American</strong><br />
Academy of Microbiology, and <strong>the</strong> <strong>American</strong><br />
<strong>Association</strong> <strong>for</strong> <strong>the</strong> Advancement of<br />
Science. She has served on Genetics Society<br />
of America board of directors and is a<br />
past president of <strong>the</strong> <strong>American</strong> Society <strong>for</strong><br />
Cell Biology. Named Cali<strong>for</strong>nia Scientist of<br />
<strong>the</strong> Year in 1999, Blackburn has received<br />
several prestigious awards, most recently<br />
<strong>the</strong> Dr. A. H. Heineken Prize <strong>for</strong> Medicine<br />
in 2004 and <strong>the</strong> 26th Annual Bristol-Myers<br />
Squibb Award <strong>for</strong> Distinguished Achievement<br />
in Cancer Research, among many<br />
o<strong>the</strong>rs. She also shared <strong>the</strong> 2006 Lasker<br />
Award <strong>for</strong> Basic Medical Research <strong>for</strong> her<br />
work on telomerases.<br />
In her plenary lecture, Blackburn will<br />
discuss current findings about telomerase<br />
activity and its role in aging and cancers.<br />
She will explain <strong>the</strong> function of telomerase,<br />
correlate long and short telomere length to<br />
human diseases, and assess <strong>the</strong> evidence<br />
that supports <strong>the</strong> idea that telomerase is<br />
necessary <strong>for</strong> cell division. cln<br />
CliniCal laboratory news speCiaL eDiTion 3
INDUSTRY WORKSHOPS<br />
Tuesday, july 29<br />
7:00 a.m.–8:30 a.m.<br />
Abbott Diagnostics<br />
Six Sigma Quality and Process Improvement<br />
with Integrated Immunochemistry Systems<br />
Speakers: Sten Westgard, MS, Director of<br />
Client Services, Westgard QC, Inc.<br />
Rob Kerekes, Charge Technologist,<br />
Core Laboratory, MLT ART, Huron Perth<br />
Healthcare Alliance—Strat<strong>for</strong>d Site<br />
Dave Armbruster, PhD, DABCC, FACB,<br />
Abbott Diagnostics, Global Scientific Affairs<br />
Manager<br />
Renaissance Hotel, Ballroom East<br />
Beckman Coulter, Inc.<br />
What is <strong>the</strong> Real Impact of WHO Standardization<br />
on PSA Results?<br />
Speakers: William J. Catalona, MD,<br />
Robert H. Lurie Comprehensive Cancer<br />
Center, Northwestern University<br />
Feinberg School of Medicine,<br />
Director, <strong>Clinical</strong> Prostate Cancer Program<br />
Kurtis R. Bray, PhD, Director,<br />
<strong>Clinical</strong> Research, Beckman Coulter, Inc.<br />
Grand Hyatt Washington, Constitution B<br />
Beckman Coulter, Inc.<br />
Achieving <strong>the</strong> Next Level: Integrated Workcells<br />
Speakers: Monica Rassai, Marketing Manager,<br />
Chemistry Systems Business Center,<br />
Beckman Coulter, Inc.<br />
Deborah L. Tennyson, Group Manager,<br />
Product Development Center,<br />
Beckman Coulter, Inc.<br />
Renaissance Hotel, Grand Ballroom Central<br />
Bio-Rad Laboratories<br />
Implementation of Automated A1c Testing<br />
from Point-of-Care to On-Demand<br />
Automation<br />
Speakers: TBD<br />
Grand Hyatt Washington, Constitution E<br />
Biosite, Inc.<br />
Assessment of Critical Conditions: ACS and<br />
AKI- How Should We Approach Them?<br />
Speakers: Kent Lewandroski, Massachusetts<br />
General Hospital, Director of <strong>Clinical</strong> Services<br />
(Anatomic and <strong>Clinical</strong>)<br />
Kenneth E. Blick, PhD, University of<br />
Oklahoma Health Sciences Center and<br />
OU Medical Center, Director of Chemistry,<br />
Point of Care and Automation<br />
Angela StraLace, Medical Center of Arlington,<br />
Chief of Emergency Services<br />
Emil Paganini, Cleveland Clinic, Head, Section<br />
of Dialysis and Extracorporeal Therapy<br />
Renaissance Hotel, Grand Ballroom South<br />
DiaSorin<br />
The Emerging Impact of Vitamin D<br />
on <strong>Clinical</strong> Management of Disease<br />
Speakers: Reinhold Vieth, PhD, FCACB,<br />
Professor, Department of Nutritional Sciences,<br />
and Department of Laboratory Medicine and<br />
Pathobiology University of Toronto Director,<br />
Bone and Mineral Laboratory, Pathology and<br />
Laboratory Medicine, Mount Sinai Hospital<br />
Bruce W. Hollis, PhD, Professor of Pediatrics;<br />
Professor of Biochemistry and Molecular Biology;<br />
Director of Pediatric Nutritional Sciences;<br />
Darby Children’s Research Institute; Medical<br />
University of South Carolina<br />
Joan Lappe, PhD, RN, FAAN, Dr. CC &<br />
Mabel L Criss & Drs. Gilbert & Clinton Beirne<br />
Endowed Chair in Nursing & Professor of<br />
Medicine; Creighton University<br />
James Edward Dowd MD, FACR, Associate<br />
<strong>Clinical</strong> Professor of Medicine, Michigan State<br />
University; Michigan Arthritis Research Center<br />
Renaissance Hotel, Ballroom West A<br />
Nanogen<br />
CPOCT—in <strong>the</strong> ED and Alternate Sites: Are<br />
We Ready <strong>for</strong> It; Is It Ready <strong>for</strong> Us?<br />
Speakers: Kenneth E. Blick, PhD, Professor,<br />
Dept of Pathology, University of Oklahoma<br />
Health Sciences Center<br />
James L. Januzzi, MD, Associate Director,<br />
Coronary Care Unit, Associate Professor of<br />
More Great Learning Opportunities<br />
6 CliniCal laboratory news speCiaL eDiTion<br />
Medicine, Harvard Medical School,<br />
Massachusetts General Hospital<br />
Alan H.B. Wu, PhD, Chief, <strong>Clinical</strong> Chemistry<br />
and Toxicology Laboratories,<br />
San Francisco General Hospital, Professor,<br />
Dept of Lab Medicine, UC San Francisco<br />
Renaissance Hotel, Auditorium<br />
Ortho<br />
Changing <strong>the</strong> Paradigm of HIV Testing in <strong>the</strong><br />
Hospital Setting With Rapid, Fully-Automated,<br />
Random Access HIV Testing<br />
Speakers: TBD<br />
Renaissance Hotel, Grand Ballroom North<br />
Psyche Systems Corporation<br />
Legacy System Connectivity and<br />
Compatibility with Emerging Technologies:<br />
How to Utilize Valuable Data While Leveraging<br />
Existing IT Infrastructure and Investment<br />
Speaker: Lisa-Jean Clif<strong>for</strong>d, Psyche Systems<br />
Corporation, Senior Director Marketing &<br />
Business Development<br />
Grand Hyatt Washington, Constitution D & E<br />
Roche<br />
Got PCR? How to Start a<br />
Molecular Diagnostics Laboratory<br />
Speaker: Art Braden, PhD, Principle Applications<br />
Scientist, Medical & Scientific Affairs,<br />
Roche Diagnostics Corporation<br />
Grand Hyatt Washington, Independence E<br />
Roche<br />
Present on Admission? Understanding <strong>the</strong><br />
Lab’s Role in Documenting Medical Severity<br />
and Contribution to Meeting <strong>the</strong> New CMS<br />
Quality Metrics<br />
Speaker: Dr. Robert S. Gold, DCBA, Inc., CEO<br />
Grand Hyatt Washington, Constitution A<br />
Roche<br />
Non-Compliance with Medication:<br />
Aiding <strong>the</strong> Clinician in Managing Patients by<br />
Providing Meaningful and Reliable Testing<br />
<strong>for</strong> Osteoporosis Therapies<br />
Speaker: Deborah T. Gold, PhD,<br />
Duke University Medical Sociology,<br />
Associate Professor of Medical Sociology<br />
Grand Hyatt, Independence G, H, I<br />
SeraCare Life Sciences<br />
Verifying and Evaluating Your Test Methods:<br />
It’s Not a Regulatory Exercise<br />
Speaker: Patricia E. Garrett, PhD, DABCC,<br />
SeraCare Life Sciences, Senior Director,<br />
Science and Technology<br />
Grand Hyatt, Independence D, E, F<br />
StanBio Laboratory<br />
Blood Ketones—Benefits Over Urine Testing<br />
and Future Applications<br />
Speaker: James H. Nichols, PhD, DABCC,<br />
FACB, Tufts University School of Medicine,<br />
Associate Professor of Pathology,<br />
Baystate Health System, Medical Director,<br />
<strong>Clinical</strong> Chemistry<br />
Grand Hyatt Washington, Independence B, C<br />
6:00 p.m.–7:30 p.m.<br />
Abbott Diagnostic<br />
Translational Medicine and <strong>the</strong><br />
<strong>Clinical</strong> Laboratory—Emerging Biomarkers<br />
<strong>for</strong> Acute Kidney Injury<br />
Speakers: Chirag Parkh, MD, PhD, FACB,<br />
Yale University, Associate Professor of Medicine<br />
Prasad Devarajan, MD, University of<br />
Cincinnati College of Medicine,<br />
Cincinnati Children’s Hospital, Professor of<br />
Pediatrics and Development Biology<br />
Renaissance Hotel, Ballroom East<br />
Abbott Diagnostics<br />
Advances in <strong>the</strong> Fluorescent<br />
Analysis of Erythrocytes<br />
Speakers: Brice H. Davis, MD, President,<br />
Trillium Diagnostics, LLC., Bangor, ME<br />
Dr. Albert Huisman, <strong>Clinical</strong> Chemist, Utrecht<br />
Medical Center, Utrecht, The Ne<strong>the</strong>rlands<br />
Renaissance Hotel, Ballroom West A<br />
Applied Biosystems<br />
Advances in <strong>the</strong> use of LC/MS/MS<br />
<strong>for</strong> <strong>the</strong> Analysis of Vitamin D, Steroids,<br />
and TDM <strong>Clinical</strong> Research<br />
Speakers: TBD<br />
Grand Hyatt, Independence G, H, I<br />
BD<br />
Improving Operational Efficiencies in <strong>the</strong> CT/<br />
GC DNA Testing Laboratory: Implementing<br />
Lean Processes with <strong>the</strong> BD Viper System<br />
Speakers: Patrick Maul, Principle Consultant,<br />
BD Diagnostics-Healthcare Consulting<br />
David Chow, Microbiology and Parasitology<br />
Manager, BC Biomedical Laboratories<br />
Grand Hyatt Washington, Independence B, C<br />
Beckman Coulter, Inc.<br />
<strong>Clinical</strong> Per<strong>for</strong>mance Comparison of<br />
Two Contemporary Cardiac Troponin Assays<br />
and <strong>the</strong> Uses of Highly Sensitive Troponin<br />
Assays in <strong>the</strong> <strong>Clinical</strong> Setting<br />
Speakers: Professor Pervenge, MD, PhD,<br />
University of Uppsala, Dept. of <strong>Clinical</strong><br />
Chemistry and Pharmacology<br />
Alan S. Jaffe, MD, Professor of Medicine<br />
Mayo Medical School<br />
Grand Hyatt Washington, Constitution B<br />
Beckman Coulter, Inc.<br />
Explore How Instrument Productivity<br />
Can Be Improved and Uptime Increased<br />
Through Remote, Internet-Based<br />
Diagnostics and Monitoring<br />
Speakers: Stephen Ishii, Marketing Manager,<br />
Chemistry System Business Center, Beckman<br />
Coulter, Inc.<br />
Ian Burgess, Group Manager, In<strong>for</strong>mation<br />
Technology, Product Development Center,<br />
Beckman Coulter, Inc.<br />
Jodey Workman, Staff Applications Scientist,<br />
Chemistry System Business Center,<br />
Beckman Coulter, Inc.<br />
Grand Hyatt Washington, Independence D, E<br />
Beckman Coulter, Inc.<br />
Per<strong>for</strong>mance of Manual Versus<br />
Lean Laboratory Automation<br />
Speaker: Dr. Ralph Dadoun, Vice President of<br />
Corporate Services, St. Mary’s Hospital Centre,<br />
Montreal<br />
Renaissance Hotel, Congressional Hall B<br />
DiaSorin<br />
The Emerging <strong>Clinical</strong> Impact of Vitamin D<br />
on <strong>Clinical</strong> Management of Disease<br />
Speakers: Reinhold Vieth, PhD, FCACB,<br />
Professor, Department of Nutritional Sciences,<br />
and Department of Laboratory Medicine and<br />
Pathobiology University of Toronto Director,<br />
Bone and Mineral Laboratory, Pathology and<br />
Laboratory Medicine, Mount Sinai Hospital<br />
Bruce W. Hollis, PhD, Professor of Pediatrics;<br />
Professor of Biochemistry and Molecular Biology;<br />
Director of Pediatric Nutritional Sciences;<br />
Darby Children’s Research Institute;<br />
Medical University of South Carolina<br />
Joan Lappe, PhD, RN, FAAN, Dr. CC &<br />
Mabel L Criss & Drs. Gilbert & Clinton Beirne<br />
Endowed Chair in Nursing & Professor of<br />
Medicine; Creighton University<br />
James Edward Dowd, MD, FACR, Associate<br />
<strong>Clinical</strong> Professor of Medicine, Michigan State<br />
University; Michigan Arthritis Research Center<br />
Renaissance Hotel, Ballroom West B<br />
Instrumentation Laboratory<br />
Effective Implementation and Management<br />
of a Point-of-Care Program<br />
Speakers: James O. Westgard, PhD, Professor,<br />
Pathology Dept. and Laboratory Medicine,<br />
University of Wisconsin<br />
Sharon L. Ehrmeyer, PhD, Professor,<br />
Pathology Dept. and Laboratory Medicine,<br />
University of Wisconsin<br />
John J. Ancy, MA, RRT, Senior <strong>Clinical</strong><br />
Consultant, Instrumentation Laboratory<br />
Grand Hyatt Washington, Constitution A<br />
Invetech<br />
If You Think You Know What a Customer<br />
Need Is, Think Again<br />
Speakers: Fred Davis, CEO, Invetech<br />
Tony Ulwick, Founder, Strategyn<br />
Renaissance Hotel, Auditorium<br />
Nanosphere, Inc.<br />
The <strong>Clinical</strong> Utility of a Highly Sensitive<br />
Cardiac Troponin Assay<br />
Speakers: W. Frank Peacock IV, MD, FACEP,<br />
Vice Chief of Emergency Medicine,<br />
Cleveland Clinic<br />
Fred S. Apple, PhD, Medical Director, <strong>Clinical</strong><br />
Laboratories, Henepin County Medical Center<br />
Renaissance Hotel, Congressional Hall B<br />
Pall Life Sciences<br />
Optimizing Diagnostic Assay<br />
Development: Material Considerations<br />
<strong>for</strong> Optimal Per<strong>for</strong>mance<br />
Speakers: Gialina Fomovska, PhD,<br />
Senior Research Scientist, Pall Corporation<br />
Martin Smith, PhD, Technical Director<br />
Pall Corporation<br />
Grand Hyatt Washington, Constitution D<br />
Thermo Fisher Scientific<br />
Implementation of LC-MS in a<br />
<strong>Clinical</strong> or Toxicology Laboratory—<br />
Assay Specific Workflows<br />
Speakers: Dr. Neil Leaver, Consultant Head of<br />
<strong>the</strong> IMS, Harefield Hospital, UK<br />
Dr. Sihe Wang, Director, Section of <strong>Clinical</strong><br />
Biochemistry, Cleveland Clinic<br />
Dr. Dennis Crouch, Director, R&D, Ameritox<br />
Grand Hyatt Washington, Constitution C<br />
Waters Corporation<br />
Ultra Per<strong>for</strong>mance Liquid Chromotogram<br />
and Tandem Mass Spectrometry <strong>for</strong> <strong>the</strong> <strong>Clinical</strong><br />
Laboratory<br />
Speakers: TBD<br />
Grand Hyatt Washington, Constitution E<br />
Wednesday, july 30<br />
7:00 a.m.–8:30 a.m.<br />
Abbott Diagnostics<br />
Current Trends in Organ Transplantation<br />
and Improved Immunoassays <strong>for</strong><br />
Therapeutic Drug Monitoring<br />
Speakers: Sudarshan Hebbar, MD,<br />
Abbott Diagnostics Medical Affairs<br />
P.Y. Wong, PhD, FCACB, Professor of<br />
Laboratory Medicine and Pathobiology,<br />
University of Toronto<br />
Daniel M. Levine, PhD, Vice President <strong>for</strong><br />
<strong>Clinical</strong> Biochemistry, The Rogosin Institute<br />
Renaissance Hotel, Ballroom East<br />
BD<br />
Maximizing Efficiency and Workflow in <strong>the</strong><br />
Laboratory Using Lean Sigma Principles<br />
Speakers: Patrick Maul, Principal Consultant,<br />
BD Diagnostics-Healthcare Consulting<br />
Dr. Ana Stankovic, World Wide Vice President,<br />
Medical and Scientific Affairs and <strong>Clinical</strong><br />
Operations, BD Preanalytical Systems<br />
Grand Hyatt Washington, Independence C, D<br />
Beckman Coulter, Inc.<br />
Anemia and Diagnostic Analysis— Finding<br />
Clues with New Biochemical Markers<br />
Speakers: Robert T. Means, Jr., MD, Professor<br />
(Hematology/Oncology Division) & Senior<br />
Associate Chair, Dept. of Internal Medicine,<br />
Interim Director, Markey Cancer Center,<br />
University of Kentucky<br />
Vernon Mustoe, PhD, Scientific Affairs<br />
Manager, Beckman Coulter, Inc.<br />
Renaissance Hotel, Ballroom West A<br />
Beckman Coulter, Inc.<br />
The Essential Role of Real Time<br />
Standardized Middleware Software<br />
in Total Laboratory Automation<br />
Speaker: Kenneth E. Blick, PhD, ACS, ABCC,<br />
FACB, Professor, Dept. of Pathology,<br />
University of Oklahoma Health Science Center<br />
Renaissance Hotel, Ballroom West B<br />
See industry Workshops, continued on p. 47
Opponents Want More Data<br />
Warfarin debate, from page 1<br />
The debate <strong>for</strong>mat represents<br />
a new twist to <strong>the</strong><br />
standard sypmposia presented<br />
at <strong>the</strong> AACC Annual<br />
Meeting. Everyone who<br />
attends <strong>the</strong> debate will get<br />
a chance to weigh in on <strong>the</strong><br />
michael Hallworth issue, Hallworth said. The<br />
audience will vote both be<strong>for</strong>e and after <strong>the</strong><br />
debate to determine if <strong>the</strong> speakers were<br />
able to sway any opinions.<br />
Proponents Emphasize Potential<br />
Shiew-Mei Huang, PhD,<br />
Deputy Director of FDA’s<br />
Office of <strong>Clinical</strong> Pharmacology,<br />
will propose a motion<br />
in favor of more wide-<br />
shiew-mei Huang<br />
spread testing, reflecting<br />
FDA’s stance on <strong>the</strong> issue.<br />
FDA’s label language, which indirectly suggests<br />
that physicians consider pharmacogenomic<br />
testing to determine initial warfarin<br />
dose, is based on data showing that doing<br />
so keeps warfarin patients’ INRs in an acceptable<br />
range of 2–3. In <strong>the</strong> absence of definitive<br />
data from randomized, controlled<br />
trials that look at harder clinical outcomes<br />
like excessive bleeding events, FDA and virtually<br />
all practitioners have used INR as a<br />
surrogate outcome, she explained.<br />
“Recent studies have showed poor patient<br />
outcomes that we need to improve<br />
upon,” Huang added, pointing to a 1,015patient<br />
study by a research team led by<br />
Brian Gage, MD, of Washington University<br />
in St. Louis. The investigators found that<br />
a dosing algorithm based on clinical factors<br />
explained 17–22% of dose variability,<br />
while ano<strong>the</strong>r algorithm that incorporated<br />
in<strong>for</strong>mation about CYP2C9 and VKO-<br />
RC1 explained 53–54% of dose variabil-<br />
8 CliniCal laboratory news speCiaL eDiTion<br />
mark linder<br />
ity (<strong>Clinical</strong> Pharmacology<br />
Therapeutics 2008 doi:<br />
10.38/clpt.2008.10).<br />
Huang also plans to<br />
discuss data that support<br />
expected cost effectiveness<br />
of widespread testing. One<br />
recent report estimates that<br />
<strong>for</strong>mally integrating genetic tests into routine<br />
warfarin <strong>the</strong>rapy could allow <strong>American</strong><br />
warfarin users to avoid between 4,500<br />
and 22,000 serious bleeding events annually,<br />
she pointed out (Personalized Medicine<br />
2008; 5: 279–284).<br />
Meanwhile, various studies also show<br />
that particular variants of <strong>the</strong> CYP2C9 and<br />
VKORC1 genes affect clearance and dose<br />
requirements. “There’s a consistent relationship.<br />
Even <strong>the</strong> worst critics of <strong>the</strong> test<br />
acknowledge this consistent<br />
and known relationship,”<br />
added Mark Linder,<br />
PhD, who is also speaking<br />
in favor of more widespread<br />
testing. Linder is<br />
Amir Jaffer<br />
Associate Director, Chemistry<br />
and Toxicology and<br />
Associate Director of <strong>the</strong> Pharmacogenetics<br />
Diagnostic Laboratory at University of<br />
Louisville Hospital in Louisville, Ky. and<br />
Senior Vice President of PGXL Laboratories,<br />
a private company that provides warfarin<br />
testing services.<br />
Wanted: Harder Outcomes<br />
Noting that <strong>the</strong> expected benefits—improved<br />
patient safety in <strong>the</strong> <strong>for</strong>m of fewer<br />
bleeding and clotting incidents—have been<br />
detailed in various reports, opponents to<br />
more widespread use of pharmacogenomic<br />
warfarin testing are waiting <strong>for</strong> hard<br />
evidence of <strong>the</strong>se benefits. “There’s good<br />
evidence that two SNPs on CYP2C9 and<br />
several on VKORC1 affect warfarin metab-<br />
Third annual<br />
olympus partnership awards<br />
presentation<br />
<strong>Monday</strong>, july 28<br />
1:30 p.m.–2:30 p.m.<br />
ballroom abc of <strong>the</strong><br />
Walter e. Washington convention center<br />
“How Healthy is <strong>the</strong><br />
Healthcare Debate on <strong>the</strong><br />
Campaign Trail and in <strong>the</strong><br />
Halls of Congress?”<br />
Cokie Roberts, Political Analyst<br />
<strong>for</strong> ABC News and National<br />
Public Radio Senior News<br />
Analyst, will share her thoughts<br />
on this timely topic.<br />
Underwritten by a grant from Olympus America.<br />
paragon dx offers<br />
Warfarin Genotyping<br />
Whatever <strong>the</strong>ir stance on warfarin pharmacogenomic testing, visitors to<br />
<strong>the</strong> Paragon Dx booth (3729) in <strong>the</strong> exhibit hall may learn <strong>the</strong>ir CYP2C9<br />
and VKORC1 genotypes at no cost. While Paragon Dx recently received<br />
FDA clearance <strong>for</strong> its Rapid Genotyping kit , <strong>the</strong> company also markets<br />
ASR reagents <strong>for</strong> lab-developed tests and will be using <strong>the</strong>m to genotype<br />
meeting attendees onsite. According to Paragon Dx CEO Michael<br />
Murphy, <strong>the</strong> company hopes to show lab directors that it’s possible to<br />
run <strong>the</strong>se warfarin pharmacogenomic tests in a space as small as <strong>the</strong><br />
company’s exhibit booth. While labs can genotype samples with Paragon<br />
Dx reagents in 60 minutes, company representatives at <strong>the</strong> meeting<br />
will be batching tests because <strong>the</strong>y expect to do several hundred of<br />
<strong>the</strong>m.<br />
olism. This we know well,” said Amir Jaffer,<br />
MD, Associate Professor of Medicine at <strong>the</strong><br />
University of Miami’s Leonard M. Miller<br />
School of Medicine and Service Chief of<br />
Medicine at Miami Hospital. “What we<br />
don’t know well is if testing translates into<br />
evidence of improved clinical outcomes.”<br />
Jaffer is speaking in opposition to more<br />
widespread testing.<br />
Both Jaffer and Charles Eby, MD, Associate<br />
Professor in <strong>the</strong> Department of Pathology<br />
and Immunology at Washington<br />
University St. Louis School of Medicine,<br />
Mo., want to see data that show warfarin<br />
pharmacogenomic testing actually reduces<br />
incidence of bleeding and mortality. Eby,<br />
who will also speak against widespread<br />
testing, considers such evidence <strong>the</strong> only<br />
true measure of <strong>the</strong> tests’ worth. “Not a single<br />
study shows a clinical benefit to testing,”<br />
he pointed out.<br />
While Huang maintained that a greater<br />
percentage of time within <strong>the</strong> target <strong>the</strong>rapeutic<br />
target range and fewer patients with<br />
INRs >4 are indeed clinical benefits, Eby<br />
noted that only two trials that have used<br />
<strong>the</strong>rapeutic INR as endpoints were randomized<br />
controlled studies. Those two<br />
studies yielded conflicting results. The first<br />
involved 206 patients and did not achieve<br />
a reduction in out-of-range INRs (Circulation<br />
2007;116: 2563–2570), but <strong>the</strong> o<strong>the</strong>r,<br />
with 201 patients, found incorporating genetic<br />
in<strong>for</strong>mation into a dosing algorithm<br />
increased patients’ time in a <strong>the</strong>rapeutic<br />
INR range (<strong>Clinical</strong> Pharmacology & Therapeutics<br />
2008; 83: 460–470). However, <strong>the</strong>se<br />
studies’ control arms employed different<br />
strategies <strong>for</strong> using genetic in<strong>for</strong>mation <strong>for</strong><br />
warfarin dosing, Eby noted.<br />
O<strong>the</strong>r Considerations<br />
Data aside, Eby raised concerns about how<br />
labs should report genetic in<strong>for</strong>mation and<br />
how clinicians would use it. “Genetic in<strong>for</strong>mation<br />
by itself has minimal value unless<br />
you put it into a dosing algorithm someone<br />
can carry around in <strong>the</strong>ir head,” he explained,<br />
“So should we provide an interpretation<br />
by saying that a particular genotype<br />
is associated with a decreased dose? Should<br />
we provide an algorithm?”<br />
Whatever labs report to physicians, “it’s<br />
more than <strong>the</strong> usual accurate, precise results,”<br />
Eby noted. While most hospital labs<br />
have experience providing specific interpretive<br />
comments <strong>for</strong> <strong>for</strong> certain tests, like<br />
D-dimer, “we’ve never had to customize results<br />
<strong>for</strong> each patient,” he pointed out. Eby<br />
also worries about labs communicating<br />
genetic in<strong>for</strong>mation to an audience much<br />
wider than <strong>the</strong> oncology subspecialties<br />
that now receive it. Lab staff may be talk-<br />
ing to clinicians who lack <strong>the</strong> education<br />
and judgment to take into consideration<br />
several o<strong>the</strong>r necessary factors— like age,<br />
body mass, sex, and use of o<strong>the</strong>r drugs—<br />
into dosing decisions, according to both<br />
Eby and Jaffer.<br />
Linder doesn’t share <strong>the</strong>se fears. He<br />
thinks opponents of wider testing are applying<br />
a double standard to <strong>the</strong> issue. They<br />
are worried about physicians learning to<br />
use <strong>the</strong> test through a process of trial and<br />
error, Linder said, but such processes are<br />
inherent to <strong>the</strong> practice of medicine in<br />
general and INR—<strong>the</strong> current standard of<br />
care—in particular. “People are applying a<br />
new set of rules to this test,” he said.<br />
Jaffer also worries that genetic data<br />
would be foisted upon physicians who are<br />
unprepared to use it safely, responsibly, and<br />
soon enough to yield benefits. One of his<br />
concerns is that existing algorithms might<br />
be too complicated <strong>for</strong> most physicians to<br />
use in routine practice. “If we make dosing<br />
more difficult, physicians might not start<br />
<strong>the</strong>rapy as soon. That would have a counter<br />
effect on how patients do,” he asserted.<br />
But complex algorithms are nothing<br />
new, according to Huang. “Physicians adjust<br />
dosage of drugs used in renal failure<br />
with algorithms that are far more complicated,”<br />
she maintained.<br />
Linder disagrees with Jaffer’s expectation<br />
that most physicians who prescribe<br />
warfarin will use <strong>the</strong> pharmacogenomic<br />
tests. “The test isn’t <strong>for</strong> all physicians, but<br />
only those who understand it. It’s available<br />
and useful now to those with specific<br />
knowledge about how to use and interpret<br />
it,” he explained.<br />
Will Huang, Eby, Linder, and Jaffer sway<br />
any opinions about warfarin pharmacogenomic<br />
testing? The best way <strong>for</strong> meeting<br />
attendees to find out is by attending what<br />
promises to be an exciting debate. cln<br />
Stop by <strong>the</strong><br />
AACC Booth<br />
#3629<br />
<strong>for</strong> <strong>the</strong> latest<br />
in<strong>for</strong>mation on all<br />
our educational<br />
programs.
The <strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Clinical</strong> Chemistry<br />
extends its sincere gratitude to <strong>the</strong> following companies <strong>for</strong> <strong>the</strong>ir<br />
generous support through <strong>the</strong>ir contributions.<br />
Abbott Diagnostics<br />
n Hotel Keycards (selected hotels)<br />
n NACB Alvin Dubin Award<br />
n Registration Portfolios<br />
n SYCL Domestic Travel Grant (through<br />
a gift to AACC’s Van Slyke Foundation)<br />
ACON Laboratories<br />
n Exhibitor Lanyards<br />
Applied Biosystems<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
n TDM/Toxicology Division<br />
Saturday Symposium<br />
AutoGenomics<br />
n AACC’s Van Slyke Foundation<br />
Silent Auction/Reception<br />
Fundraiser Support<br />
BD Diagnostics—<br />
Preanalytical Systems<br />
n International Travel Fellowship Award<br />
n International Travel Grants (through<br />
a gift to AACC’s Van Slyke Foundation)<br />
Beckman Coulter, Inc<br />
n Award <strong>for</strong> Outstanding Contributions<br />
through Service to <strong>the</strong> Profession of<br />
<strong>Clinical</strong> Chemistry<br />
n International Travel Grant (through a<br />
gift to AACC’s Van Slyke Foundation)<br />
n Student Travel Grants (through a gift<br />
to AACC’s Van Slyke Foundation)<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
n Carl Jolliff Award <strong>for</strong> Lifetime<br />
Achievement in <strong>Clinical</strong> or<br />
Diagnostic Immunology<br />
n Garry Labbe Award <strong>for</strong><br />
Contributions to Laboratory<br />
Assessment of Nutritional Status<br />
n Nutrition Division<br />
Saturday Symposium<br />
Bio-Rad Laboratories<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
IVD Technology Magazine<br />
n International Marketing Seminar<br />
Fluidigm<br />
n Notepads and Pens<br />
Diagnostica Stago, Inc<br />
n ClinPack Door Drop Bags (selected<br />
hotels)<br />
Fujirebio Diagnostics, Inc<br />
n Attendee Lanyards<br />
Gen-Probe, Inc.<br />
n Molecular Pathology Division Town<br />
Hall Meeting<br />
Genzyme<br />
n Student Poster Contest (through a<br />
gift to AACC’s Van Slyke Foundation)<br />
n Student Oral Presentation Contest<br />
(through a gift to AACC’s Van Slyke<br />
Foundation)<br />
ITC<br />
n CyberLink Email Stations<br />
LifeScan<br />
n Point-of-Care Coordinator<br />
of <strong>the</strong> Year Award<br />
Luminex Molecular<br />
Diagnostics<br />
n Molecular Pathology Division<br />
Townhall Meeting<br />
Nova Biomedical<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
Olympus America, Inc.,<br />
Diagnostic Systems<br />
n Award <strong>for</strong> Outstanding Contributions<br />
in a Selected Area of Research<br />
n International Travel Grants<br />
(through a gift to AACC’s Van Slyke<br />
Foundation)<br />
n Exhibit Hall Lounge Beverage Breaks<br />
n Lead Retrieval Cards<br />
Osmetech<br />
n Molecular Pathology Division Town<br />
Hall Meeting<br />
Ortho <strong>Clinical</strong> Diagnostics<br />
n Program and Exhibit Guides<br />
n Award <strong>for</strong> Outstanding <strong>Clinical</strong><br />
Laboratory Contributions to<br />
Improving Patient Safety<br />
Perkin Elmer<br />
n AACC’s Van Slyke Foundation<br />
Silent Auction/Reception<br />
Fundraiser Support<br />
Promega<br />
n Molecular Pathology Division Town<br />
Hall Meeting<br />
Quest Diagnostics<br />
Hospital Services<br />
n Award <strong>for</strong> Outstanding Contributions<br />
in Education<br />
Roche Diagnostics<br />
n Award <strong>for</strong> Outstanding<br />
Scientific Achievements<br />
by a Young Investigator<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
n Molecular Pathology Division<br />
Town Hall Meeting<br />
Siemens Healthcare<br />
Diagnostics<br />
n AACC Lectureship Award<br />
n Outstanding Lifetime Achievement<br />
Award in <strong>Clinical</strong> Chemistry and<br />
Laboratory Medicine<br />
n The Morton K. Schwartz Award <strong>for</strong><br />
Significant Contributions in <strong>Clinical</strong><br />
Chemistry<br />
n Award <strong>for</strong> Outstanding Contribution<br />
<strong>for</strong> a Publication in <strong>the</strong> International<br />
Journal, <strong>Clinical</strong> Chemistry<br />
n The Edwin I. Ullman Award<br />
n Aisle Banner Signage<br />
n NACB Distinguished Scientist Award<br />
n <strong>Clinical</strong> & Diagnostic Immunology<br />
Division Issues in Immunodiagnostics<br />
Symposium<br />
n <strong>American</strong> Board of <strong>Clinical</strong> Chemistry<br />
Reception<br />
Suntec Medical, Inc.<br />
n Young Investigator Award <strong>for</strong><br />
Outstanding Research in Molecular<br />
Pathology or Pharmacogenomics<br />
Thermo Fisher Scientific<br />
n TDM/Toxicology Division<br />
Saturday Symposium<br />
Utak Laboratories, Inc.<br />
n Utak Young Investigator Award in<br />
Therapeutic Drug Management<br />
and Toxicology<br />
Waters Corporation<br />
n Molecular Pathology Division<br />
Town Hall Meeting<br />
n TDM/Toxicology Division<br />
Saturday Symposium<br />
CliniCal laboratory news Special edition 9
2008 AACC AwA r d wi n n e r s<br />
<strong>Clinical</strong> Laboratory Science Leaders Receive Awards<br />
At <strong>the</strong> opening plenary session of <strong>the</strong> 2008 Annual Meeting, a dozen leaders in <strong>the</strong> field of clinical laboratory medicine were<br />
recognized <strong>for</strong> <strong>the</strong>ir outstanding contributions. AACC President Larry A. Broussard, PhD, DABCC, FACB, and representatives of <strong>the</strong><br />
sponsoring companies presented <strong>the</strong> awards. AACC and CLN are proud to note a few of <strong>the</strong>ir many accomplishments below.<br />
The AACC Lectureship Award<br />
Sponsored by an educational grant from<br />
Siemens Healthcare Diagnostics<br />
P. Roy Vagelos, MD<br />
Dr. Vagelos is retired chairman<br />
and CEO of Merck<br />
& Co. He served as senior<br />
surgeon and section head<br />
of comparative biochemistry<br />
at <strong>the</strong> National Institutes<br />
of Health <strong>for</strong> a decade. In 1966, he<br />
became chair of <strong>the</strong> department of biological<br />
chemistry at <strong>the</strong> Washington University<br />
School of Medicine in St. Louis and in 1973<br />
founded <strong>the</strong> university’s division of biology<br />
and biomedical sciences. He joined Merck<br />
in 1975 as senior vice president <strong>for</strong> research<br />
and became president of its research division<br />
in 1976. In 1985, he became CEO, a<br />
post from which he retired in 1994. Be<strong>for</strong>e<br />
assuming broader responsibilities of business<br />
leadership, Dr. Vagelos had won scientific<br />
recognition as an authority on lipids<br />
and enzymes and as a research manager.<br />
The author of more than 100 scientific<br />
papers, he received <strong>the</strong> Enzyme Chemistry<br />
Award of <strong>the</strong> <strong>American</strong> Chemical Society<br />
in 1976. He is a member of <strong>the</strong> National<br />
Academy of Sciences, <strong>the</strong> <strong>American</strong> Academy<br />
of Arts and Sciences, and <strong>the</strong> <strong>American</strong><br />
Philosophical Society. He has received<br />
14 honorary doctorates, and his many<br />
awards in science and business include <strong>the</strong><br />
Lawrence A. Wien Prize in Social Responsibility<br />
from Columbia University and <strong>the</strong><br />
National Academy of Sciences Award <strong>for</strong><br />
Chemistry in Service to Society. He served<br />
as chairman of <strong>the</strong> board of <strong>the</strong> University<br />
of Pennsylvania and chairs <strong>the</strong> board of<br />
visitors at Columbia University Medical<br />
Center. He is currently chair of Regeneron<br />
Pharmaceuticals and Theravance, two biotech<br />
companies.<br />
Outstanding Lifetime Achievement Award in<br />
<strong>Clinical</strong> Chemistry and Laboratory Medicine<br />
Sponsored by Siemens Healthcare Diagnostics<br />
Mary F. Burritt, PhD, FACB, HCLD<br />
(ABB)<br />
Dr. Burritt is professor of<br />
laboratory medicine at<br />
<strong>the</strong> Mayo Clinic College<br />
of Medicine and clinical<br />
chemist at Mayo Clinic<br />
Arizona in Scottsdale. She<br />
previously held <strong>the</strong> positions of medical<br />
co-director of <strong>the</strong> Central <strong>Clinical</strong> Laboratory<br />
and director of <strong>the</strong> Metals Laboratory<br />
at <strong>the</strong> Mayo Clinic as well as associate dean<br />
of <strong>the</strong> Mayo School of Health Sciences in<br />
Rochester, Minn. Dr. Burritt has served<br />
AACC in many roles over <strong>the</strong> past 30 years,<br />
including president in 1996 and chair of<br />
<strong>the</strong> annual meeting organizing committee<br />
in 2000. Dr. Burritt has been active in <strong>the</strong><br />
<strong>Clinical</strong> and Laboratory Standards Insti-<br />
10 CliniCal laboratory news Special edition<br />
tute, serving as chair of <strong>the</strong> Subcommittee<br />
on Electrolytes, as chair of <strong>the</strong> Area Committee<br />
on <strong>Clinical</strong> Chemistry <strong>for</strong> 5 years,<br />
and as a member of <strong>the</strong> Volunteer Resources/Program<br />
Committee. She has also been<br />
active on <strong>the</strong> international level, serving as<br />
<strong>the</strong> vice chair of <strong>the</strong> Education and Management<br />
Division and chair of <strong>the</strong> visiting<br />
lecturer program of <strong>the</strong> International<br />
Federation <strong>for</strong> <strong>Clinical</strong> Chemistry and<br />
Laboratory Medicine (IFCC) <strong>for</strong> 6 years<br />
in each position. Among her contributions<br />
in education and research, she directed <strong>the</strong><br />
postdoctoral training program in clinical<br />
chemistry at <strong>the</strong> Mayo Clinic <strong>for</strong> 8 years.<br />
She has lectured extensively both nationally<br />
and internationally on many topics<br />
including technical and clinical aspects of<br />
ionized calcium, POCT, quality systems,<br />
and automation. Dr. Burritt has published<br />
more than 195 peer-reviewed articles, abstracts,<br />
and chapters.<br />
The Morton K. Schwartz Award <strong>for</strong> Significant<br />
Contributions in Cancer Research Diagnostics<br />
Sponsored by Siemens Healthcare Diagnostics<br />
Martin Fleisher, PhD, FACB<br />
Dr. Fleisher is chair of <strong>the</strong><br />
department of clinical<br />
laboratories and director<br />
of <strong>the</strong> clinical chemistry<br />
laboratory at <strong>the</strong> Memorial<br />
Sloan-Kettering Cancer<br />
Center in New York City. Dr. Fleisher joined<br />
<strong>the</strong> medical staff at Memorial Sloan-Kettering<br />
as an assistant attending biochemist<br />
and spent 35 years working closely with <strong>the</strong><br />
award’s namesake, Dr. Morton K. Schwartz,<br />
<strong>the</strong>n chair of <strong>the</strong> department of biochemistry.<br />
Dr. Fleisher has spent his career in<br />
<strong>the</strong> study, discovery, and development of<br />
tumor markers and biomarkers in cancer<br />
detection. His interest in biomarkers began<br />
in 1970 with <strong>the</strong> validation of carcinoembryonic<br />
antigen in colon cancer. His seminal<br />
work on <strong>the</strong> relationship between breast<br />
cancer and cystic mastopathy involved<br />
more than 1,000 women, whose breast cyst<br />
fluids were analyzed <strong>for</strong> more than 80 analytes.<br />
He investigated <strong>the</strong> use of biomarkers<br />
in node-negative women with breast cancer<br />
and developed methods to monitor <strong>the</strong>rapy<br />
that are still in use at many medical centers.<br />
In collaboration with his neuro-oncology<br />
colleagues, he developed cerebrospinal fluid<br />
tumor markers. Dr. Fleisher’s current research<br />
focuses on <strong>the</strong> use of biomarkers <strong>for</strong><br />
new targeted preclinical and clinical drug<br />
development and <strong>the</strong> identification of gene<br />
expression patterns in cancer metastasis.<br />
An active member of AACC since 1968, Dr.<br />
Fleisher has served as national treasurer, a<br />
member of <strong>the</strong> board of directors, co-chair<br />
of <strong>the</strong> 1993 annual meeting, and in many<br />
o<strong>the</strong>r positions. He is a member of <strong>the</strong><br />
board of directors of <strong>the</strong> National Academy<br />
of <strong>Clinical</strong> Biochemistry and president of<br />
<strong>the</strong> <strong>Clinical</strong> Ligand Assay Society.<br />
Award <strong>for</strong> Outstanding<br />
Contributions in Education<br />
Sponsored by Quest Diagnostics Nichols Institute<br />
William E. Winter, MD, DABCC,<br />
FACB<br />
Dr. Winter is a professor<br />
in <strong>the</strong> departments of pathology,<br />
immunology, and<br />
laboratory medicine; pediatrics;<br />
and molecular genetics<br />
and microbiology at<br />
<strong>the</strong> University of Florida College of Medicine<br />
in Gainesville. Dr. Winter directed <strong>the</strong><br />
pathology residency training program at<br />
<strong>the</strong> University of Florida <strong>for</strong> 10 years be<strong>for</strong>e<br />
being appointed as course director <strong>for</strong><br />
<strong>the</strong> second year medical student pathology<br />
course in 2004. He has given numerous<br />
presentations and has published extensively<br />
on behalf of AACC. With Dr. M.<br />
Signorino, he authored AACC’s monograph,<br />
Diabetes Mellitus. With Drs. I. Jialal<br />
and D. Chan, he co-authored AACC’s<br />
Handbook of Diagnostic Endocrinology. A<br />
five-time winner of <strong>the</strong> AACC Outstanding<br />
Speaker Award, Dr. Winter served on <strong>the</strong><br />
AACC Annual Meeting Organizing Committee<br />
in 1998 and 2003 and is presently on<br />
<strong>the</strong> 2009 committee. He chaired <strong>the</strong> organizing<br />
committee <strong>for</strong> AACC’s professional<br />
practice in clinical chemistry course in 2005<br />
and 2007 and chairs <strong>the</strong> 2009 course. He is<br />
a fellow of <strong>the</strong> National Academy of <strong>Clinical</strong><br />
Biochemistry and <strong>the</strong> College of <strong>American</strong><br />
Pathologists. He is currently a member<br />
of <strong>the</strong> board of directors of <strong>the</strong> National<br />
Academy of <strong>Clinical</strong> Biochemistry. Including<br />
articles, chapters, and abstracts, he has<br />
contributed nearly 200 publications that<br />
deal with chemistry, coagulation, diabetes,<br />
endocrinology, and immunology.<br />
Award <strong>for</strong> Outstanding Contributions<br />
In a Selected Area of Research<br />
Sponsored by Olympus America Inc.,<br />
Diagnostic Systems<br />
Marilyn A. Huestis, PhD<br />
Dr. Huestis is a tenured<br />
senior investigator and <strong>the</strong><br />
chief of <strong>the</strong> chemistry and<br />
drug metabolism section<br />
of <strong>the</strong> clinical pharmacology<br />
and <strong>the</strong>rapeutics<br />
research branch at <strong>the</strong> NIDA in Be<strong>the</strong>sda,<br />
Md. She holds an adjunct associate professor<br />
appointment at <strong>the</strong> University of<br />
Maryland in Baltimore. She directs a large<br />
research program that seeks to discover <strong>the</strong><br />
mechanisms of action of cannabinoid agonists<br />
and antagonists, <strong>the</strong> effects of in utero<br />
drug exposure, and <strong>the</strong> neurobiology and<br />
pharmacokinetics of MDMA (ecstasy). Dr.<br />
Huestis currently is <strong>the</strong> principal investigator<br />
of a phase I clinical study evaluating<br />
cognitive per<strong>for</strong>mance and related brain<br />
activation of acute and chronic cannabis<br />
exposure using functional magnetic resonance<br />
imaging. The study also investigates<br />
and contrasts spontaneous and antagonistelicited<br />
cannabis withdrawal. Dr. Huestis<br />
was director of one of <strong>the</strong> first <strong>for</strong>ensic<br />
urine drug testing laboratories among 150<br />
applicants to be certified by NIDA. She<br />
serves on <strong>the</strong> World Anti-doping Agency’s<br />
Prohibited List Committee and <strong>the</strong> U.S.<br />
Anti-Doping Agency’s Research Advisory<br />
Panel. Dr. Huestis is past president of <strong>the</strong><br />
Society of Forensic Toxicologists, past chair<br />
of <strong>the</strong> Toxicology Section of <strong>the</strong> <strong>American</strong><br />
Academy of Forensic Sciences, and <strong>the</strong> first<br />
woman president of <strong>the</strong> International <strong>Association</strong><br />
of Forensic Toxicologists. She has<br />
published 145 peer-reviewed manuscripts,<br />
published numerous book chapters and<br />
monographs, and presented more than<br />
220 abstracts at national and international<br />
meetings.<br />
Award <strong>for</strong> Outstanding <strong>Clinical</strong> Laboratory<br />
Contributions to Improving Patient Safety<br />
Sponsored by Ortho <strong>Clinical</strong> Diagnostics<br />
Mario Plebani, MD, FACB<br />
Dr. Plebani is full professor<br />
of clinical chemistry and<br />
clinical molecular biology<br />
at <strong>the</strong> University of Padova<br />
School of Medicine, chief<br />
of <strong>the</strong> department of laboratory<br />
medicine at <strong>the</strong> University Hospital<br />
of Padova, chief of <strong>the</strong> Center of Biomedical<br />
Research (a specialized center <strong>for</strong> quality<br />
in laboratory medicine <strong>for</strong> <strong>the</strong> Veneto<br />
Region), and scientific coordinator of <strong>the</strong><br />
regional anti-doping laboratory at <strong>the</strong> University<br />
Hospital in Padova, Italy. He served<br />
as president of <strong>the</strong> International Society of<br />
Enzymology <strong>for</strong> 5 years and of <strong>the</strong> Italian<br />
Society of <strong>Clinical</strong> Biochemistry and Molecular<br />
<strong>Clinical</strong> Biology <strong>for</strong> 4 years. He currently<br />
serves on <strong>the</strong> AACC Patient Safety<br />
Advisory Group and <strong>the</strong> International Advisory<br />
Group. Dr. Plebani is reviews editor<br />
of <strong>Clinical</strong> Chemistry and Laboratory Medicine,<br />
associate editor of <strong>Clinical</strong> Biochemistry,<br />
CRC <strong>Clinical</strong> Laboratory Sciences, and<br />
International Journal of Biological Markers<br />
and editor-in-chief of a journal on clinical<br />
governance. His main areas of research are<br />
quality in laboratory medicine, biomarkers<br />
in cancer and cardiovascular diseases,<br />
and in vitro allergy diagnostics. He has<br />
published 560 original papers, including a<br />
widely cited paper in <strong>Clinical</strong> Chemistry in<br />
1997 dealing with errors in a stat laboratory<br />
that received great acceptance. In 2007 he<br />
published a new paper in <strong>the</strong> same journal<br />
describing <strong>the</strong> laboratory errors situation<br />
after 10 years. He is guest editor of a special<br />
issue of <strong>Clinical</strong> Chemistry and Laboratory<br />
Medicine dedicated to “Laboratory<br />
Medicine and Patient Safety” and author<br />
of many papers on <strong>the</strong> topic of laboratory<br />
errors and patient safety.<br />
AACC Awards, continued on page 12
AACC Awards, from page 10<br />
Award <strong>for</strong> Outstanding Contributions<br />
Through Service to <strong>the</strong> Profession<br />
Sponsored by Beckman Coulter, Inc.<br />
Susan A. Evans, PhD, FACB<br />
Dr. Evans is vice president<br />
and general manager of<br />
Agencourt Bioscience, a<br />
Beckman Coulter Company<br />
in Beverly, Mass., that<br />
provides genomic services<br />
and nucleic acid purification products <strong>for</strong><br />
clinical and life science researchers. She<br />
has more than 25 years of experience in<br />
<strong>the</strong> diagnostic industry, holding leadership<br />
positions in research and development and<br />
now general management. She has developed<br />
assays <strong>for</strong> analytes in <strong>the</strong> areas of endocrinology,<br />
fertility, cardiac markers, and<br />
TDM. Dr. Evans’s involvement with AACC<br />
began in <strong>the</strong> 1980s, when she served as an<br />
officer in <strong>the</strong> Florida Section and continued<br />
with local section activities in San Diego<br />
and Chicago. Her service to AACC on<br />
<strong>the</strong> national level includes being elected to<br />
<strong>the</strong> board of directors, as national secretary,<br />
and as president in 2003. She chaired <strong>the</strong><br />
Program Coordinating Commission twice,<br />
was one of <strong>the</strong> founding members of <strong>the</strong><br />
Industry Division, and is vice chair of <strong>the</strong><br />
2008 Annual Meeting Organizing Committee.<br />
She currently serves as president<br />
of <strong>the</strong> National Academy of <strong>Clinical</strong> Biochemistry,<br />
where she has also served on <strong>the</strong><br />
board of directors. Dr. Evans has also volunteered<br />
her time to <strong>the</strong> IFCC, including<br />
as secretary and corporate representative to<br />
its Education and Management Division,<br />
and to <strong>the</strong> <strong>Clinical</strong> Laboratory Standards<br />
Institute through membership on several<br />
committees.<br />
Award <strong>for</strong> Outstanding Scientific<br />
Achievements by a Young Investigator<br />
Sponsored by Roche Diagnostics<br />
Alex J. Rai, PhD, DABCC, FACB<br />
Dr. Rai is an assistant attending<br />
clinical chemist<br />
in <strong>the</strong> clinical chemistry<br />
service of <strong>the</strong> department<br />
of pathology at Memorial<br />
Sloan-Kettering Can-<br />
12 CliniCal laboratory news Special edition<br />
cer Center in New York City. During his<br />
fellowship training at <strong>the</strong> Johns Hopkins<br />
University School of Medicine, Dr. Rai<br />
focused on proteomics- and bioin<strong>for</strong>matics-based<br />
biomarker discovery in ovarian<br />
cancer, in addition to his clinical service<br />
training. His current research interests lie<br />
in <strong>the</strong> discovery of novel biomarkers <strong>for</strong><br />
cancer and <strong>the</strong>ir translation into clinically<br />
useful diagnostic tests. Recent projects<br />
have included biomarker discovery using<br />
multiplexed gene expression profiling and<br />
proteomics techniques, and development<br />
of assays <strong>for</strong> multiplexed single nucleotide<br />
polymorphism analysis. He is interested in<br />
designing, evaluating, and validating tests<br />
<strong>for</strong> stratifying cancer subtypes and identifying<br />
patients unable to metabolize chemo<strong>the</strong>rapeutic<br />
drugs. By stratifying a patient’s<br />
disease based on biomarker profiles and<br />
screening patient genotypes prior to <strong>the</strong>ir<br />
starting <strong>the</strong>rapy, treatment of a patient’s<br />
cancer and selection of <strong>the</strong> most appropriate<br />
<strong>the</strong>rapeutic regimen can be tailored.<br />
Dr. Rai has published more than 20 scientific<br />
articles and presented more than 25<br />
invited lectures nationally and internationally.<br />
He serves on committees <strong>for</strong> several<br />
professional organizations, including <strong>the</strong><br />
New York Metro Section of AACC, <strong>the</strong> National<br />
Academy of <strong>Clinical</strong> Biochemistry,<br />
and <strong>the</strong> <strong>Clinical</strong> Ligand Assay Society.<br />
International Travel Fellowship<br />
Sponsored by BD Diagnostics—<br />
Preanalytical Systems<br />
Renze Bais, PhD<br />
Dr. Bais is chief operating<br />
officer of Pacific Laboratory<br />
Medicine Services and<br />
clinical senior lecturer in<br />
<strong>the</strong> department of medicine<br />
at <strong>the</strong> University of<br />
Sydney. He is also an associate of <strong>the</strong> Royal<br />
College of Pathologists of Australasia. He<br />
has been involved in research and development<br />
in a variety of areas and published<br />
more than 90 scientific papers and book<br />
chapters and over 100 abstracts of presentations<br />
at both national and international<br />
meetings. He recently co-authored<br />
two chapters on enzymology <strong>for</strong> <strong>the</strong> Tietz<br />
Textbook of <strong>Clinical</strong> Chemistry and <strong>for</strong> Fundamentals<br />
of <strong>Clinical</strong> Chemistry. He has<br />
been active with <strong>the</strong> IFCC <strong>for</strong> many years,<br />
Genzyme Student Oral<br />
Presentations and Poster Contest<br />
<strong>Monday</strong>, July 28<br />
2:00 p.m.–4:30 p.m.<br />
Renaissance Washington, D.C. Hotel<br />
Congressional Hall B and C<br />
This symposium, which highlights research by students, offers presentations<br />
of student abstracts in both oral and poster <strong>for</strong>mats. The first hour<br />
consists of oral presentations from <strong>the</strong> four students who received <strong>the</strong><br />
highest scores in <strong>the</strong> preliminary judging phase of <strong>the</strong> contest, and <strong>the</strong><br />
remainder of <strong>the</strong> afternoon consists of students competing in <strong>the</strong> poster<br />
contest. Students will compete <strong>for</strong> cash awards as <strong>the</strong>y are judged on<br />
scientific content, originality, and presentation style. These events provide<br />
an inspiring glimpse of <strong>the</strong> future leaders in laboratory medicine.<br />
This program is funded by a generous gift provided by<br />
Genzyme Corporation to <strong>the</strong> Van Slyke Foundation.<br />
including 6 years as a member of Scientific<br />
Division Executive committee and 5 years<br />
as a member of <strong>the</strong> executive board and<br />
federation secretary. Dr. Bais has held various<br />
positions within <strong>the</strong> Australasian <strong>Association</strong><br />
of <strong>Clinical</strong> Biochemists, including<br />
chair of both <strong>the</strong> South Australian and<br />
New South Wales Branches, vice president,<br />
and chair of <strong>the</strong> Scientific and Regulatory<br />
Affairs Committee. For <strong>the</strong> past 5 years,<br />
Dr. Bais has been <strong>the</strong> Australian coordinator<br />
of <strong>the</strong> Australasian <strong>Association</strong> of<br />
<strong>Clinical</strong> Biochemists/Vietnamese <strong>Association</strong><br />
of <strong>Clinical</strong> Biochemistry joint project<br />
on quality assurance. This project aims to<br />
develop quality systems <strong>for</strong> Vietnamese<br />
laboratories and to set up quality assurance<br />
programs in Vietnam. He plans to use<br />
this International Travel Fellowship award<br />
to fur<strong>the</strong>r <strong>the</strong> development of quality systems<br />
and assurance programs in Sou<strong>the</strong>ast<br />
Asian countries.<br />
The Edwin F. Ullman Award<br />
Sponsored by Siemens Healthcare Diagnostics<br />
John F. Burd, PhD<br />
Dr. Burd is a co-founder<br />
and general partner of<br />
Sabur Technology in San<br />
Diego, Calif., a company<br />
dedicated to developing<br />
unique medical testing<br />
products. Previously, he was founder and<br />
CEO of Oculir, Inc., which developed a remarkable<br />
new non-invasive analyte testing<br />
technology. Dr. Burd has been a leader in a<br />
large number of companies involved in developing<br />
medical devices. He was a general<br />
partner of Windamere Venture Partners,<br />
a firm that started more than 15 medical<br />
product and biotechnology companies<br />
during his tenure. He was CEO of Mira-<br />
Medica, a company developing computeraided<br />
detection technology <strong>for</strong> enhanced<br />
cancer diagnosis that was sold to Kodak in<br />
August 2003. As president and CEO of Dex-<br />
Com, he directed <strong>the</strong> company’s work to<br />
develop, manufacture, and market <strong>the</strong> first<br />
long-term implantable glucose sensor. He<br />
was <strong>the</strong> founder of LXN Corp., which developed<br />
<strong>the</strong> Duet Diabetes Control System<br />
and <strong>the</strong> In Charge Diabetes Control System.<br />
LXN was sold to Johnson and Johnson in<br />
2000. At Quidel Corp., he directed <strong>the</strong> development<br />
of enzyme immunoassay products<br />
<strong>for</strong> <strong>the</strong> clinical laboratory, physician’s<br />
office, and home markets. As executive vice<br />
president of Mast Immunosystems, his responsibilities<br />
included research and development,<br />
marketing, sales, and finance. Dr.<br />
Burd began his career developing fluorescent<br />
immunoassays and per<strong>for</strong>ming medical<br />
product research and development at<br />
Miles Laboratories. Dr. Burd has authored<br />
and co-authored numerous articles and his<br />
work has led to 25 patents and <strong>the</strong> development<br />
of many innovative products.<br />
The AACC Past President’s Award<br />
Gary L. Myers, PhD, FACB<br />
Dr. Myers is chief of <strong>the</strong><br />
clinical chemistry branch<br />
at <strong>the</strong> Centers <strong>for</strong> Disease<br />
Control and Prevention<br />
(CDC) in Atlanta, Ga. He<br />
also serves as <strong>the</strong> scientific<br />
director of <strong>the</strong> World Health Organization<br />
Collaborating Center <strong>for</strong> Reference and<br />
Research in Blood Lipids at <strong>the</strong> CDC. His<br />
30-year career at <strong>the</strong> CDC has focused on<br />
improving <strong>the</strong> laboratory measurement of<br />
biochemical markers used to assess chronic<br />
disease risk, particularly cardiovascular<br />
disease. Dr. Myers has served AACC at all<br />
levels, including chair of <strong>the</strong> Lipids and Lipoproteins<br />
Division, 2002 Annual Meeting<br />
Organizing Committee, and 2006 Beckman<br />
Conference. He has served on <strong>the</strong><br />
Meetings Management Group, Nominating<br />
Committee, and Board of Directors.<br />
Under his leadership, 2007 was an exciting<br />
and busy year <strong>for</strong> AACC as it made progress<br />
in all of its strategic initiatives. It was<br />
also a transitional year, as Dr. Myers directed<br />
<strong>the</strong> search <strong>for</strong> a new editor-in-chief <strong>for</strong><br />
AACC’s flagship journal, <strong>Clinical</strong> Chemistry.<br />
It was a special year <strong>for</strong> <strong>the</strong> Web site Lab<br />
Tests Online, which expanded into six new<br />
countries, including Australia, Germany,<br />
Hungary, Italy, Poland, and Spain. Lab Tests<br />
Online is recognized as <strong>the</strong> premier online<br />
source <strong>for</strong> in<strong>for</strong>mation about laboratory<br />
testing. The Personalized Medicine Advisory<br />
Group was <strong>for</strong>med to recommend how<br />
AACC should embrace and become active<br />
in this rapidly expanding area. Ano<strong>the</strong>r<br />
important initiative was partnering with<br />
<strong>the</strong> <strong>Association</strong> <strong>for</strong> Molecular Pathology<br />
to develop and offer a molecular pathology<br />
review course in 2008.<br />
Award <strong>for</strong> Outstanding Contribution<br />
For a Publication in <strong>the</strong> International<br />
Journal <strong>Clinical</strong> Chemistry<br />
Sponsored by Siemens Healthcare Diagnostics<br />
Hassan Dihazi, PhD<br />
Dr. Dihazi is associate professor,<br />
group leader of proteomics<br />
in <strong>the</strong> department<br />
of nephrology and rheumatology,<br />
and director<br />
of <strong>the</strong> clinical proteomics<br />
facility at <strong>the</strong> Georg-August University in<br />
Göttingen, Germany. His research focuses<br />
on key proteins connecting cellular stress response<br />
pathways to renal diseases. His group<br />
also seeks to develop new clinical proteomics<br />
approaches <strong>for</strong> earlier diagnosis of human<br />
diseases and biomarker discovery. Dr.<br />
Dihazi is a council member of <strong>the</strong> Human<br />
Kidney and Urine Proteomics Project and<br />
<strong>the</strong> European Kidney and Urine Proteomics<br />
<strong>Association</strong>. He is also <strong>the</strong> co-founder of <strong>the</strong><br />
Göttingen Proteomics Forum. He is involved<br />
in several proteomics journals as an editorial<br />
board member and is editor-in-chief<br />
of Proteomics Insights. He has published a<br />
number of articles on proteomics, especially<br />
<strong>the</strong>ir relation to kidney function. In his winning<br />
article, “Characterization of diabetic<br />
nephropathy by urinary proteomic analysis:<br />
identification of a processed ubiquitin <strong>for</strong>m<br />
as differentially excreted protein in diabetic<br />
nephropathy patients,” Dr. Dihazi described<br />
a robust procedure <strong>for</strong> <strong>the</strong> identification and<br />
characterization of proteins differentially excreted<br />
in <strong>the</strong> urine of diabetic patients with<br />
microalbuminuria and/or macroalbuminuria.<br />
He also identified indicators of tissue<br />
injury in urine that may result in clinical<br />
applications <strong>for</strong> early diagnosis of diabetes<br />
mellitus-related nephropathy. The paper’s<br />
co-authors were Gerhard A. Mueller, Sandra<br />
Lindner, Markus Meyer, Abdul R. Asif,<br />
Michael Oellerich, and Frank Strutz (Clin<br />
Chem 2007; 53:9, 1636–1645).
NACB 2008 Award Winners<br />
Through its annual awards program, NACB, <strong>the</strong> Academy of AACC, celebrates <strong>the</strong> achievements of colleagues who have made significant<br />
contributions through scholarship and service to <strong>the</strong> profession. Chaired by Dr. Elizabeth Frank, <strong>the</strong> NACB Awards Committee wishes to<br />
thank <strong>the</strong> sponsors of <strong>the</strong>se awards and to congratulate <strong>the</strong> 2008 award winners.<br />
DISTINGUISHED SCIENTIST AWARD<br />
For Outstanding Research Advances in<br />
<strong>the</strong> Field of <strong>Clinical</strong> Biochemistry<br />
Sponsored by Siemens Healthcare Diagnostics,<br />
Inc.<br />
Gerald R. Cooper, MD, PhD, DABCC,<br />
FACB<br />
Gerald R. Cooper, MD, PhD,<br />
has made AACC and NACB<br />
his professional home. In<br />
1952, he joined <strong>the</strong> Communicable<br />
Disease Center<br />
(CDC) to establish a<br />
chemistry laboratory. In 1954, he received<br />
<strong>the</strong> <strong>American</strong> Medical <strong>Association</strong> Hektoen<br />
Award <strong>for</strong> his methodology research<br />
on paper electrophoresis. In 1955, he coauthored<br />
a paper published in <strong>the</strong> first issue<br />
of <strong>the</strong> journal <strong>Clinical</strong> Chemistry. In<br />
1956, Dr. Cooper was appointed Chief,<br />
CDC Chemistry, Hematology and Pathology<br />
Laboratories.<br />
In 1978, Dr. Cooper transferred to a Research<br />
Medical Officer appointment in <strong>the</strong><br />
CDC <strong>Clinical</strong> Chemistry Branch, where he<br />
participated in cardiovascular disease services<br />
and research, mainly on cholesterol<br />
and lipoprotein biomarker risk factors. He<br />
was chair of <strong>the</strong> outstanding AACC Cholesterol<br />
Reference Method Study that led<br />
<strong>the</strong> way <strong>for</strong> CDC to develop a chemical<br />
cholesterol reference method and <strong>for</strong> NIST<br />
to develop a definitive cholesterol reference<br />
mass spectrometry method. Dr. Cooper directed<br />
<strong>the</strong> central laboratory <strong>for</strong> <strong>the</strong> NHLBI<br />
Coronary Drug Project <strong>for</strong> 52 cardiovascular<br />
clinics and was responsible <strong>for</strong> <strong>the</strong><br />
laboratory standardization of more than 30<br />
clinical trials, including <strong>the</strong> NHLBI Lipid<br />
Research Clinics trial and Multiple Risk<br />
Factor Intervention Trial. He continues today<br />
to serve as Research Medical Officer <strong>for</strong><br />
<strong>the</strong> <strong>Clinical</strong> Chemistry Branch and Medical<br />
Director of <strong>the</strong> WHO Collaborating Center<br />
<strong>for</strong> Reference and Research in Blood Lipids<br />
established at CDC.<br />
GEORGE GRANNIS AWARD<br />
For Excellence in Research<br />
and Scientific Publication<br />
Sponsored by NACB with support from <strong>the</strong><br />
AACC Ohio Valley Section<br />
Amy K. Saenger, PhD<br />
Amy K. Saenger received<br />
her PhD in chemistry from<br />
<strong>the</strong> University of Minnesota<br />
in 2004. For her <strong>the</strong>sis, she<br />
studied human mutations<br />
in <strong>the</strong> short-chain acyl-CoA<br />
dehydrogenase enzymes. After completing<br />
her graduate studies, Dr. Saenger joined <strong>the</strong><br />
<strong>Clinical</strong> Chemistry Fellowship Program<br />
at <strong>the</strong> University of Washington in Seattle.<br />
Here, she expanded her research interests<br />
to include novel risk markers <strong>for</strong> oxidative<br />
stress and development of new testing using<br />
LC-MS/MS. In 2006, Dr. Saenger joined<br />
<strong>the</strong> staff at <strong>the</strong> Mayo Clinic as <strong>the</strong> Director<br />
of <strong>the</strong> Central <strong>Clinical</strong> Laboratory and<br />
Central Processing and Assistant Professor<br />
of Laboratory Medicine within <strong>the</strong> College<br />
of Medicine. Her current research interests<br />
include novel biomarkers <strong>for</strong> detection of<br />
oxidative and cardiovascular stress, dam-<br />
age, and heart failure.<br />
Dr. Saenger has been <strong>the</strong> recipient<br />
of several honors and awards, including<br />
grants from <strong>the</strong> <strong>American</strong> Heart <strong>Association</strong><br />
in 1997, and pre-doctoral grants<br />
from <strong>the</strong> NIH (2000–2003). She has been<br />
honored twice with <strong>the</strong> Paul E. Strandjord<br />
Young Investigator Award from <strong>the</strong> Academy<br />
of <strong>Clinical</strong> Physicians and Scientists in<br />
2005 and 2006 and <strong>the</strong> Strandjord/Clayson<br />
Award <strong>for</strong> Meritorious Research from <strong>the</strong><br />
University of Washington, Department of<br />
Laboratory Medicine in 2006.<br />
ALVIN DUBIN AWARD<br />
For Outstanding Contributions to <strong>the</strong><br />
Profession and <strong>the</strong> Academy<br />
Sponsored by Abbott Diagnostics<br />
Ronald J. Whitley, PhD, DABCC,<br />
FACB<br />
Ronald Whitley, PhD, is<br />
Professor, Department of<br />
Pathology and Director,<br />
<strong>Clinical</strong> Chemistry and<br />
Core Laboratories, University<br />
of Kentucky. He<br />
received his BS degree in chemistry from<br />
Georgia Tech. He attended graduate<br />
school in biochemistry at Emory University<br />
and returned to Georgia Tech to earn<br />
his PhD in organic chemistry (1975). After<br />
completing a 3-year NIH postdoctoral<br />
fellowship in endocrinology at <strong>the</strong> Mayo<br />
Clinic, he remained in Rochester and<br />
trained <strong>for</strong> an additional 2 years in clinical<br />
chemistry.<br />
Dr. Whitley joined <strong>the</strong> faculty of <strong>the</strong><br />
NACB Congratulates <strong>the</strong><br />
2008 Distinguished Abstract Award Recipients<br />
University of Kentucky in 1980. He oversees<br />
dozens of laboratory procedures and is<br />
responsible <strong>for</strong> validation of new tests, instruments<br />
and technologies in <strong>the</strong> core laboratory,<br />
special chemistry, and POCT services.<br />
He also helps assess <strong>the</strong> significance<br />
of unusual test results, directs a chemistry<br />
training program <strong>for</strong> pathology residents,<br />
and participates in clinical conferences<br />
and didactic teaching sessions with medical<br />
students, pediatric residents, endocrine<br />
fellows, and medical technology graduate<br />
students.<br />
His scientific interests include applications<br />
of immunoassays and mass spectometry<br />
to endocrine and genetic disorders. He<br />
authored or co-authored <strong>the</strong> general endocrine,<br />
thyroid, adrenal and catecholamine<br />
chapters in <strong>the</strong> Tietz Textbook of <strong>Clinical</strong><br />
Chemistry, 3rd edition, and authored <strong>the</strong><br />
endocrine and amino acids sections in <strong>the</strong><br />
<strong>Clinical</strong> Guide to Laboratory Tests, 2nd and<br />
3rd editions. He has helped developed consensus-based<br />
guidelines <strong>for</strong> using tumor<br />
markers in thyroid cancer and <strong>for</strong> follow-up<br />
testing of metabolic diseases identified by<br />
expanded newborn screening. He has also<br />
helped develop CLSI consensus documents<br />
<strong>for</strong> immunoassay systems and newborn<br />
screening blood collections.<br />
Dr. Whitley is a Diplomate of <strong>the</strong><br />
<strong>American</strong> Board of <strong>Clinical</strong> Chemistry, an<br />
active member of AACC, and a fellow of<br />
NACB. He currently serves as a member<br />
of <strong>the</strong> NACB Expanded Newborn Screening<br />
Guidelines Committee. He has served<br />
AACC and NACB in a variety of leadership<br />
roles.<br />
A panel of NACB Fellows selected <strong>the</strong> following 26 abstracts as representing scientific excellence worthy of special recognition from <strong>the</strong> 725<br />
accepted abstracts. Look <strong>for</strong> <strong>the</strong> NACB blue ribbon on <strong>the</strong>se distinguished abstracts in <strong>the</strong> poster sessions.<br />
Tuesday, July 29, 10:00 a.m. Qing H. Meng (B-65)<br />
John Ferrara (A-97)<br />
The role of procalcitonin in <strong>the</strong> diagnosis<br />
of sepsis and patient assignment to<br />
medical intensive care.<br />
Amy Mondelblatt (A-99)<br />
Traditional igh-esolution CSF protein<br />
electrophoresis is ineffective in detecting<br />
oligoclonal banding.<br />
Qing H Meng (A-113)<br />
Trans<strong>for</strong>ming growth factor-ß1 is a<br />
potential marker <strong>for</strong> kidney damage in<br />
patients with essential hypertension:<br />
renoprotective effect of ACE inhibitor<br />
and/or angiotensin II receptor blocker.<br />
Paul R Desjardins (A-120)<br />
Comparing <strong>the</strong> clinical effectiveness of<br />
fetal fibronectin and IGFBP-1 measurements<br />
in cervico-vaginal secretions, in<br />
predicting preterm deliveries.<br />
Tuesday, July 29, 2:00 p.m.<br />
Beneficial effects of soy isoflavones on<br />
insulin secretion, glucose control, and<br />
cataract prevention in streptozotocininduced<br />
diabetic rats.<br />
Larry H. Bernstein (B-80)<br />
Correcting NT-ProBNP level <strong>for</strong> effect of<br />
renal function impairment.<br />
Pete Kavsak (B-134)<br />
Preliminary investigation of a high<br />
sensitivity PAPP-A research assay in an<br />
Acute Coronary Syndrome population.<br />
Alexander Semenov (B-141)<br />
The difference in glycosylation between<br />
human proBNP and NT-proBNP suggests<br />
a new regulatory level in proBNP<br />
processing.<br />
Paul O. Collinson (B-146)<br />
The second international collaborative<br />
study of N-terminal pro B type natriuretic<br />
peptide (NTproBNP) in primary<br />
care (ICON II-PC).<br />
Lorin M. Bachmann (B-27)<br />
A novel proteomics plat<strong>for</strong>m <strong>for</strong> LCtandem<br />
MS-based quantification of<br />
differentially expressed proteins in<br />
complex biofluids.<br />
Amy K. Saenger (B-153)<br />
Modulation and relationship of brain<br />
natriuretic peptides to estrogen and<br />
androgens, as investigated in a pediatric<br />
population.<br />
John R. Petersen (B-41)<br />
Jordi Ordonez-Llanos (B-157)<br />
Evaluation of <strong>the</strong> APRI (AST, platelet A <strong>for</strong>mula combining ST2 and NT-<br />
ratio index) and ELF (Enhanced Liver proBNP enhances prognostic accuracy<br />
Fibrosis) tests to detect significant<br />
14 CliniCal laboratory news Special edition in patients with heart failure.<br />
fibrosis due to chronic hepatitis C.<br />
Wednesday, July 30, 10:00 a.m.<br />
Naohito Ishii (C-10)<br />
Hemodialysis suppresses nitrotyrosine<br />
residue <strong>for</strong>mation in patients with<br />
diabetes mellitus.<br />
Zhimin Cao (C-42)<br />
Poor interlaboratory agreement of<br />
testosterone measurements using<br />
HPLC-tandem mass spectrometry.<br />
Jagadish Ulloor (C-70)<br />
Dynamics of testosterone and SHBG<br />
interaction.<br />
Wednesday, July 30, 2:00 p.m.<br />
Johan Frostegård (D-29)<br />
Low levels of antibodies against phosphorylcholine<br />
predict development of<br />
a<strong>the</strong>rosclerosis.<br />
Amar A Sethi (D-32)<br />
Pre-beta HDL is a strong positive diagnostic<br />
risk marker <strong>for</strong> ischemic heart<br />
disease in subjects with both high and<br />
low HDL-C levels. The Copenhagen City<br />
Heart Study.<br />
Werner Steimer (D-52)<br />
Influence of Cyp1A2*1F polymorphism<br />
on olanzapine serum concentrations<br />
and clinical outcome.<br />
Werner Steimer (D-54)<br />
Influence of Cyp2C19 polymorphisms<br />
on citalopram serum concentrations<br />
and clinical outcome.<br />
Kristen K. Reynolds (D-70)<br />
Accuracy of genotype-based<br />
warfarin dose estimation and plasma<br />
S-warfarin pharmacokinetic modeling.<br />
Alexander Haliassos (D-104)<br />
Early markers of acute kidney injury in<br />
ICU multitrauma patients. Preliminary<br />
report.<br />
Michael I. Watkins (D-147)<br />
Hemolysis interference does not equal<br />
hemoglobin interference; Non-hemoglobin<br />
interference by <strong>the</strong> hemolysate<br />
of red blood cells (RBC).<br />
Thursday, July 31, 10:00 a.m.<br />
Mark A. Cervinski (E-10)<br />
Qualitative point-of-care (POC) and<br />
over-<strong>the</strong>-counter (OTC) urine hCG<br />
devices detect various iso<strong>for</strong>ms of hCG<br />
during early pregnancy.<br />
Soumaya El Rouby (E-22)<br />
Monitoring heparin <strong>the</strong>rapy during<br />
cardiopulmonary bypass and cardiac<br />
interventional ca<strong>the</strong>terization in pediatrics.<br />
Shu-Ling Liang (E-95)<br />
Falsely-elevated acetaminophen results<br />
in icteric and hemolyzed specimens.
Divisions Recognize Contributions to Laboratory Medicine<br />
AACC’s divisions recognize <strong>the</strong> achievements and contributions of <strong>the</strong>ir colleagues through awards and travel grants.<br />
The divisions offer congratulations to <strong>the</strong> following 2008 award winners:<br />
AnimAl CliniCAl Chemistry Division<br />
Award <strong>for</strong> Outstanding Contributions<br />
to Animal <strong>Clinical</strong> Chemistry<br />
Sponsored by Siemens Healthcare Diagnostics<br />
N. Leigh Anderson, PhD, CEO, Plasma<br />
Proteome Institute, Washington, DC<br />
Outstanding Research in Animal<br />
<strong>Clinical</strong> Laboratory Medicine<br />
To be announced.<br />
CliniCAl & DiAgnostiC immunology Division<br />
International Travel Grant<br />
Adelani Adebisi, FMCPath, University of<br />
Ilorin, Nigeria<br />
Carl Jolliff Award <strong>for</strong> Lifetime<br />
Achievement in <strong>Clinical</strong> or<br />
Diagnostic Immunology<br />
Ishwarlal Jialal, MD, PhD, UC Davis<br />
Medical Center, Sacramento, Calif.<br />
Outstanding Research in <strong>Clinical</strong><br />
and Diagnostic Immunology<br />
Lei Zhu, University of Helsinki,<br />
Helsinki, Finland<br />
Detecting PSA-API Based on Proximity<br />
Ligation Assay<br />
CritiCAl AnD Point-0f-CAre testing Division<br />
Point-of-Care Coordinator of <strong>the</strong> Year<br />
Peggy Mann, University of Texas Medical<br />
Branch, Texas City, Texas<br />
Outstanding Research in Critical Care<br />
or Point-of-Care Testing<br />
Soumaya El Rouby, PhD, ITC,<br />
Piscatawa, NJ<br />
Monitoring Heparin Therapy during<br />
Cardiopulmonary Bypass and Cardiac<br />
Interventional Ca<strong>the</strong>terization in Pediatrics<br />
Research Grant Recipient<br />
Dr. Subir Kumar Das, Amrita Institute of<br />
Medical Sciences, Kerala, India<br />
Role of Adipocytokines and Inflammatory<br />
Processes in Insulin Resistance<br />
CORPORATE MEMBERS<br />
Leaders ($100,000 and over)<br />
Abbott Diagnostics<br />
Patrons ($25,000 to $49,999)<br />
Beckman Coulter<br />
PerkinElmer<br />
Olympus America Inc.<br />
Contributors ($10,000 to $24,999)<br />
BD Diagnostics<br />
AutoGenomics, Inc.<br />
Genzyme<br />
Donors ($100 to $4,999)<br />
Bio-Research Products, Inc.<br />
AACC LOCAL SECTIONS & DIVISIONS<br />
Sponsors ($10,000 to $49,999)<br />
Midwest Local Section<br />
TDM & <strong>Clinical</strong> Toxicology<br />
Division<br />
Sustainers ($5,000 to $9,999)<br />
Chicago Local Section<br />
<strong>Clinical</strong> & Diagnostic Immunology<br />
Division<br />
Critical and POCT Division<br />
Management Sciences Division<br />
Rocky Mountain Local Section<br />
Sou<strong>the</strong>rn Cali<strong>for</strong>nia Local Section<br />
Patrons ($1,000 to $4,999)<br />
Capital Section of <strong>the</strong> AACC<br />
Sou<strong>the</strong>ast Local Section<br />
Connecticut Valley Local Section<br />
16 CliniCal laboratory news Special edition<br />
history Division<br />
Carraway-Meites Award <strong>for</strong><br />
Enhancing our Knowledge of<br />
<strong>the</strong> History of <strong>Clinical</strong> Chemistry<br />
Nathan Radin, PhD, Stone Mountain, Ga.<br />
inDustry Division<br />
Louis J. Dunka Jr. Memorial<br />
Service Award<br />
To be announced.<br />
Best Abstract of Interest<br />
to <strong>the</strong> Industry Division<br />
To be announced.<br />
lAborAtory in<strong>for</strong>mAtion systems<br />
AnD meDiCAl in<strong>for</strong>mAtiCs Division<br />
Award <strong>for</strong> Outstanding Research<br />
in Medical In<strong>for</strong>matics<br />
Ken Blick, PhD, University of Oklahoma<br />
Health Science Center,<br />
Oklahoma City, Okla.<br />
Real-Time quality control based on patient<br />
running means (PRM) <strong>for</strong> total laboratory<br />
automation (TLA) using Beckman Coulter<br />
(BCI) DL2000 middleware.<br />
liPoProteins AnD vAsCulAr DiseAses Division<br />
Cooper Award <strong>for</strong> Outstanding Contributions<br />
to Service in <strong>the</strong> Area of<br />
Lipoproteins and Vascular Diseases<br />
Ishwarlal Jialal, MD, PhD, UC Davis<br />
Medical Center, Sacramento, Calif.<br />
Pacific Biometrics Research Foundation<br />
Award <strong>for</strong> Contributions to <strong>the</strong><br />
Technology of <strong>Clinical</strong> Chemistry<br />
Takashi Miida, MD, PhD, Juntendo University<br />
School of medicine, Tokyo, Japan<br />
International Travel Grant<br />
Lorena Ivona Stefan, MSc,<br />
<strong>Clinical</strong> Emergency Hospital, Romania<br />
Outstanding Article in<br />
Fats of Life Newsletter<br />
To be announced.<br />
Poster Award Winners<br />
Three awards are given <strong>for</strong> outstanding<br />
abstracts accepted in <strong>the</strong> area of lipopro-<br />
teins and vascular diseases. Recipients are<br />
announced in Fats of Life.<br />
mAnAgement sCienCes Division<br />
Award <strong>for</strong> Outstanding Research in<br />
Management Sciences<br />
Ping Li, West China Hospital,<br />
Chengdu, China<br />
Application of six sigma metric to assess total<br />
quality per<strong>for</strong>mance of clinical laboratory.<br />
moleCulAr PAthology Division<br />
Outstanding Research in <strong>the</strong><br />
Area of Molecular Pathology<br />
or Pharmacogenomics<br />
Alicia Algeciras-Schimnich, PhD,<br />
Mayo Clinic, Rochester, Minn.<br />
<strong>Clinical</strong> assay <strong>for</strong> <strong>the</strong> detection of <strong>the</strong><br />
PAX8-PPARγ granslocation in follicular<br />
thyroid cancer<br />
Young Investigator Award <strong>for</strong><br />
Outstanding Research in Molecular<br />
Pathology or Pharmacogenomics<br />
Grigory Tsaur, MD, PhD,<br />
Regional Children’s Hospital,<br />
Yekaterinburg, Russian Federation<br />
Minimal residual disease monitoring of<br />
MLL-EPS15 fusion gene in infants’ acute<br />
leukemia using quantitative real-time PCR<br />
assay.<br />
Student/Medical Technologist Award<br />
<strong>for</strong> Outstanding Research in Molecular<br />
Pathology or Pharmacogenomics<br />
Zhen Yang, MS, University of Texas<br />
Medical Branch, Galveston, Texas<br />
HIV-1 genotypic resistance test in specimens<br />
with a low viral load<br />
nutrition Division<br />
Gary Labbe Award <strong>for</strong> Contributions<br />
to Laboratory Assessment of<br />
Nutritional Status<br />
Jose M. Ordovas, PhD, Tufts University,<br />
Boston, Mass.<br />
Award <strong>for</strong> Outstanding Research in<br />
Nutrition. 1st Place.<br />
Yanping Gong, PhD, University of<br />
Toronto, Toronto, Ontario, Canada<br />
Chronic pain as a sign of a higher vitamin D<br />
requirement<br />
Award <strong>for</strong> Outstanding Research in<br />
Nutrition. 2nd Place.<br />
Nadheige Lochard, PhD, CHU Ste-<br />
Justine, University of Montreal, Montreal,<br />
QC, Canada<br />
Effect of paraoxonase 1 gene polymorphism<br />
on lipid profile in children and adolescents<br />
PeDiAtriC & mAternAl-fetAl Division<br />
Award <strong>for</strong> Outstanding<br />
Contributions to Pediatric and<br />
Maternal-Fetal <strong>Clinical</strong> Chemistry<br />
John E. Sherwin, PhD, Perkin Elmer,<br />
Huntington Station, N.Y.<br />
Best Poster Award<br />
Oluyemi Akinloye, PhD,<br />
Ladoke Akintola University of Technology,<br />
Osogbo, Osun State, Nigeria<br />
Relationship between maternal and infants’<br />
plasma and breast milk levels of some<br />
selected micronutrients.<br />
Student and Young<br />
Faculty Poster Award<br />
Octavia Peck-Palmer, PhD,<br />
Washington University School of Medicine,<br />
St. Louis, Mo.<br />
Intra-individual variability of basic chemistry<br />
tests in a pediatric population.<br />
Alexander Haliassos, MD, PhD,<br />
Diamedica, A<strong>the</strong>ns, Greece<br />
Evaluation of pregnancy associated plasma<br />
protein A (PAPP-A) and free beta human<br />
chorionic gonadotrophin (free ß-hCG)<br />
on Siemens Immulite in comparison with<br />
Brahms Kryptor analyzer.<br />
<strong>the</strong>rAPeutiC Drug monitoring<br />
& CliniCAl toxiCology Division<br />
UTAK Young Investigator Award<br />
Paul Jannetto, PhD, Medical College of<br />
Wisconsin, Milwaukee, Wis.<br />
VAN SLYKE FOUNDATION HONOR ROLL<br />
The Foundation gratefully recognizes contributors who made donations totaling $100 or more from January 1, 2007, through May 20, 2008.<br />
On behalf of all <strong>the</strong> promising science students and laboratorians in <strong>the</strong> developing world who received VSF grants and awards,<br />
we extend our sincere thanks. These contributions have helped to advance clinical laboratory medicine worldwide.<br />
Lipoproteins & Vascular Diseases<br />
Division<br />
Pacific Northwest Local Section<br />
Molecular Pathology Division<br />
Contributors ($100 to $999)<br />
North Carolina Local Section<br />
INDIVIDUAL MEMBERS<br />
Leaders ($100,000 and over)<br />
Gopal Savjani<br />
Gerald and Sandy Gallwas<br />
Benefactor ($50,000 to $99,000)<br />
Thomas Adams<br />
Sponsors ($10,000 to $49,999)<br />
Jocelyn Hicks<br />
Richard Nadeau<br />
Mary Lou Gantzer<br />
Robert Habig<br />
Sustainers ($5,000 to $9,999)<br />
Robert Stout<br />
Laurence Demers<br />
D. Robert Dufour<br />
Jan Krouwer<br />
Marilyn A. Huestis<br />
Patrons ($1,000 to $4,999)<br />
Nathan Gochman<br />
Helen Free<br />
Susan Evans<br />
Basil Doumas<br />
Geoffrey Moyer<br />
Masashi Itano<br />
Alan Runck<br />
Charles Galanaugh<br />
Robert Murray<br />
Mathias Muller<br />
John Sherwin<br />
Mary Burritt<br />
Fred Apple<br />
Gerald Cooper<br />
Darrin Scherago<br />
William Luft<br />
Frederick Brazda<br />
Julius Kerkay<br />
Ann Gronowski<br />
Roger Calam<br />
Carl Garber<br />
Don Miyada<br />
James Faix<br />
Imre Fischer<br />
Tsan Liu<br />
Michael Kleerekoper<br />
Susan Gross<br />
Donald Powers<br />
Marion Mixson<br />
Kathleen Quill<br />
Morton Schwartz<br />
Ruth McNair<br />
Jacob Levine<br />
Richard Lent<br />
Gail Mutnik<br />
Contributors ($100 to<br />
$999)<br />
Larry Broussard<br />
Thomas Williams<br />
John O'Malley<br />
Sally Hojvat<br />
Earl Soules<br />
Deji Deji<br />
Daniel Farkas<br />
Christine Papadea<br />
Enno Logemann<br />
Douglas Stickle<br />
James Ritchie<br />
Isaac Rosenzweig<br />
Jesse Goodwin<br />
Stephen Stroupe<br />
Paula Santrach<br />
Charles Hawker<br />
Donald Forman<br />
Clara Sumeghy<br />
Ching-Nan Ou<br />
Harold Choitz<br />
Samuel Ma<strong>the</strong>ws<br />
Esokpan Ebose<br />
Richard Collins<br />
Ka<strong>the</strong>rine Chen<br />
Robert Johnson<br />
Carlotta Eisen<br />
Edward Ashwood<br />
Eugene Garcia<br />
Phyllis Feinblum<br />
Jean Travers<br />
William Roberts<br />
Carolyn Bergkuist<br />
David Grenache<br />
Harold Brown<br />
Gary Myers<br />
Harold Williams<br />
Alan Wu<br />
Akin Williams<br />
Sarah Mook<br />
Cheong Ngoi<br />
Beryl Weinstein<br />
Dan Chen<br />
Corinne Fantz<br />
Kevin Cavanagh<br />
Steven Lobel<br />
Masayuki Totani<br />
Nori Jones<br />
Sophia Kakari<br />
David Keren<br />
Toshifumi Niwa<br />
John Mason<br />
Michael Sheff<br />
Nathan Radin<br />
Claudio Sampaio<br />
William Feldman<br />
James McQuaid<br />
Daniel Hoefner<br />
Howard Ludwick<br />
Stanley Lo<br />
Michael Bennett<br />
Harald Drews<br />
Harvey Kaufman<br />
Dalamaga Androniki<br />
Irwin Oreskes<br />
Luciano Marchetti<br />
Barbara Cooper<br />
Adebowale Alabi<br />
James Smith<br />
Olusegun Mojiminiyi<br />
Geza Bodor<br />
Paula Childs<br />
Juan Paz-Fernandez<br />
Harold Baker<br />
Mary Jackson<br />
Linda Gorman<br />
Arturo Vargas<br />
Bobby Boyanton<br />
Barbara Zehnbauer<br />
Philip Boglo<br />
Barclay Whitaker<br />
Patricia Jones<br />
Tina Sky<br />
John Williams<br />
Gregory Tsongalis<br />
Willard Faulkner<br />
Maggie Bruno<br />
Penelope Jones<br />
Patrick St. Louis<br />
Gyorgy Abel<br />
James Nichols<br />
Special Gifts<br />
The Foundation extends special thanks to Mr.<br />
Gopal Savjani, whose generous donation created<br />
<strong>the</strong> Past Presidents’ Scholarships <strong>for</strong> Post-doctoral<br />
Training. To date, four scholarships have been<br />
awarded in ComACC-approved training programs.<br />
The VSF also thanks Jerry and Sandy Gallwas<br />
<strong>for</strong> <strong>the</strong>ir ongoing generosity that funds AACC<br />
memberships, travel grants, and educational<br />
opportunities <strong>for</strong> deserving scientists from <strong>the</strong><br />
developing world.<br />
Planned Gifts<br />
The VSF gratefully acknowledges <strong>the</strong> following<br />
generous bequests from <strong>the</strong> following donors:<br />
Earl Scherago<br />
Elizabeth K. Smith<br />
Contributions to <strong>the</strong> VSF Memorial Fund were<br />
made in memory of Joseph Napolitano.
18 CliniCal laboratory news Special edition<br />
3M Medical Diagnostics . . . . . . . . . . . .3921<br />
A/C Diagnostics LLC . . . . . . . . . . . . . . . .2148<br />
A2LA ................................344<br />
AACC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3629<br />
AAFP-Laboratory Proficiency Testing .162<br />
Aalto Scientific, Ltd. . . . . . . . . . . . . . . . .3833<br />
Abaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .366<br />
Abbott Diagnostics .................1507<br />
Abbott Diagnostics Labs Are Vital . . .1811<br />
AbD Serotec . . . . . . . . . . . . . . . . . . . . . . .3733<br />
Access Bio, Inc. . . . . . . . . . . . . . . . . . . . . .4149<br />
Access Biological . . . . . . . . . . . . . . . . . . .1965<br />
AccuTest, Inc. . . . . . . . . . . . . . . . . . . . . . . .3910<br />
ACON Laboratories, Inc. . . . . . . . . . . . . .1038<br />
AcroMetrix . . . . . . . . . . . . . . . . . . . . . . . . .4109<br />
Adaltis US Inc. . . . . . . . . . . . . . . . . . . . . . .3215<br />
Adaptive MFG. Technologies Inc. . . . .2353<br />
ADEMTECH . . . . . . . . . . . . . . . . . . . . . . . . . .109<br />
Adhesives Research, Inc. . . . . . . . . . . . .1847<br />
Adicon <strong>Clinical</strong> Laboratories, Inc. . . . .1042<br />
Advance . . . . . . . . . . . . . . . . . . . . . . . . . . .3049<br />
Advanced Instruments, Inc. . . . . . . . . . .230<br />
Advanced Liquid Logic . . . . . . . . . . . . . .164<br />
Advanced Microdevices Pvt. Ltd. . . . .1769<br />
Aesku Diagnostics . . . . . . . . . . . . . . . . . .1653<br />
Affymetrix, Inc. . . . . . . . . . . . . . . . . . . . . . .410<br />
Agilent Technologies . . . . . . . . . . . . . . .3148<br />
Ahlstrom . . . . . . . . . . . . . . . . . . . . . . . . . . .4108<br />
AID GmbH ...........................126<br />
Alfa Scientific Designs, Inc. . . . . . . . . . . .156<br />
Alfa Wassermann<br />
Diagnostic Technologies . . . . . . . . .1031<br />
ALIFAX SPA . . . . . . . . . . . . . . . . . . . . . . . . .3315<br />
ALPCO Diagnostics . . . . . . . . . . . . . . . . .1546<br />
AMA Scientific, LLC . . . . . . . . . . . . . . . . .4104<br />
Amano Enzyme USA Co., Ltd. . . . . . . . .130<br />
Amedica Biotech, Inc. . . . . . . . . . . . . . . .1963<br />
<strong>American</strong> Bio Medica Corporation . . . .258<br />
<strong>American</strong> Diagnostica Inc. . . . . . . . . . .1044<br />
<strong>American</strong> Medical Technologists . . . . .118<br />
<strong>American</strong> Proficiency Institute . . . . . .3628<br />
ASCLS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3039<br />
<strong>American</strong> Society <strong>for</strong><br />
<strong>Clinical</strong> Pathology . . . . . . . . . . . . . . . .4125<br />
Ameritek USA . . . . . . . . . . . . . . . . . . . . . . .113<br />
Amic AB . . . . . . . . . . . . . . . . . . . . . . . . . . . . .261<br />
Analis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1129<br />
Analyticon Biotechnologies AG . . . . .1461<br />
Anew International . . . . . . . . . . . . . . . . .3703<br />
Ani Biotech Oy &<br />
AniLabsystems Ltd ...............1756<br />
Antek HealthWare . . . . . . . . . . . . . . . . . .2115<br />
Applied Biosystems ..................903<br />
APS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2067<br />
Argene Inc. . . . . . . . . . . . . . . . . . . . . . . . . .2268<br />
Aries Filterworks,<br />
Division of ResinTech .............1859<br />
Arista Biologicals Inc. . . . . . . . . . . . . . . .2152<br />
Arlington Scientific - ASI . . . . . . . . . . . .1524<br />
Artel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .757<br />
ARUP Laboratories . . . . . . . . . . . . . . . . .1039<br />
ARUP Laboratories . . . . . . . . . . . . . . . . .4032<br />
Asahi Kasei Pharma Corporation . . . . .120<br />
ASCO Numatics .....................2253<br />
ASSEL - AMS ........................1563<br />
Asuragen, Inc. . . . . . . . . . . . . . . . . . . . . . .3046<br />
A<strong>the</strong>ra Biotechnologies .............1359<br />
A<strong>the</strong>rotech . . . . . . . . . . . . . . . . . . . . . . . . . .133<br />
Atlas Link, Inc. . . . . . . . . . . . . . . . . . . . . . . .169<br />
Audit MicroControls, Inc. ............3829<br />
Autobio Diagnostics Co. Ltd. . . . . . . . . .204<br />
AutoGenomics Inc. . . . . . . . . . . . . . . . . .1023<br />
Awareness Technology, Inc. . . . . . . . . .1803<br />
AWEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1130<br />
Axis-Shield . . . . . . . . . . . . . . . . . . . . . . . . . .357<br />
AZOG, Inc. ...........................142<br />
Bangs Laboratories, Inc. .............1014<br />
Baytree Leasing ......................123<br />
BBInternational . . . . . . . . . . . . . . . . . . . . .3431<br />
BD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .339<br />
BD Lee Laboratories . . . . . . . . . . . . . . . .1661<br />
Beau<strong>for</strong>t Advisors ....................115<br />
Beckman Coulter, Inc. . . . . . . . . . . . . . . .2025<br />
Beijing Kinghawk Pharmaceuticals . .2954<br />
Beijing Shining Sun<br />
Technology Co., Ltd. . . . . . . . . . . . . . .3716<br />
Berthold Detection Systems GmbH . .1863<br />
BERTHOLD TECHNOLOGIES GmbH ...1355<br />
Bestgen Biotech Corp. . . . . . . . . . . . . . .3929<br />
Binding Site Inc., The . . . . . . . . . . . . . . . . .923<br />
Binding Site Inc., The . . . . . . . . . . . . . . . .2153<br />
BioAssay Works, LLC .................3923<br />
Bio-Bottle Ltd . . . . . . . . . . . . . . . . . . . . . .1466<br />
BioCheck, Inc. . . . . . . . . . . . . . . . . . . . . . .2262<br />
Bio-Chem Fluidics . . . . . . . . . . . . . . . . . .1960<br />
BioDot, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .3912<br />
BIOER TECHNOLOGY Co., LTD ........1553<br />
BioHelix Corporation . . . . . . . . . . . . . . . .362<br />
BIOHIT, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .3615<br />
BioKit SA . . . . . . . . . . . . . . . . . . . . . . . . . . . .543<br />
Biological Specialty Corporation . . . .2364<br />
Biologix Research Co. . . . . . . . . . . . . . . .2160<br />
BIOLYPH, LLC . . . . . . . . . . . . . . . . . . . . . . .1860<br />
Biomat . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1358<br />
BioMed Resource Inc. . . . . . . . . . . . . . . .2358<br />
Biomedix . . . . . . . . . . . . . . . . . . . . . . . . . . . .465<br />
bioMerieux, Inc. . . . . . . . . . . . . . . . . . . . .1743<br />
Bioneer Corporation . . . . . . . . . . . . . . . .1662<br />
BioPorto Diagnostics . . . . . . . . . . . . . . .1259<br />
BioProcessing, Inc. . . . . . . . . . . . . . . . . . . .208<br />
Bio-Rad Laboratories . . . . . . . . . . . . . . .1239<br />
Biosearch Technologies, Inc. . . . . . . . . .101<br />
Biosigma S.R.L. . . . . . . . . . . . . . . . . . . . . .1554<br />
Biosino Bio-Technology<br />
& Science Inc. . . . . . . . . . . . . . . . . . . . .2851<br />
Biosource . . . . . . . . . . . . . . . . . . . . . . . . . .1127<br />
BIOSPACIFIC . . . . . . . . . . . . . . . . . . . . . . . .1760<br />
Bio-Syn<strong>the</strong>sis, Inc. . . . . . . . . . . . . . . . . . . .960<br />
BioTek Instruments, Inc. . . . . . . . . . . . . . .244<br />
Biotest Diagnostic Corp . . . . . . . . . . . . .3011<br />
BioTX Automation, Inc. . . . . . . . . . . . . . .768<br />
BioVentures, Inc. . . . . . . . . . . . . . . . . . . . .4051<br />
Biowin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1125<br />
BIT Analytical Instruments . . . . . . . . . .2267<br />
BloodCenter of Wisconsin . . . . . . . . . . .968<br />
Blue Cross Bio-Medical<br />
Beijing Co., Ltd. . . . . . . . . . . . . . . . . . .1357<br />
BODITECH MED Inc. . . . . . . . . . . . . . . . . .161<br />
BOMI IBERICA, S.A. . . . . . . . . . . . . . . . . . . .349<br />
Brady Corporation . . . . . . . . . . . . . . . . . .4043<br />
Burkert Fluid Control Systems . . . . . . . .657<br />
C & A Scientific Co., Inc. . . . . . . . . . . . . .4145<br />
CalBioreagents . . . . . . . . . . . . . . . . . . . . .3812<br />
Calbiotech Inc . . . . . . . . . . . . . . . . . . . . . .2910<br />
Caldon Bioscience . . . . . . . . . . . . . . . . . .3808<br />
Calypte Biomedical Corporation . . . .4045<br />
Calzyme Laboratories, Inc. . . . . . . . . . .2249<br />
Cambridge Consultants . . . . . . . . . . . . . .311<br />
CapitalBio Corporation . . . . . . . . . . . . .1667<br />
Capralogics Inc . . . . . . . . . . . . . . . . . . . . . .112<br />
Capricorn Products LLC . . . . . . . . . . . . . .214<br />
Cardinal Health . . . . . . . . . . . . . . . . . . . . . .843<br />
CARE Diagnostica Int’l . . . . . . . . . . . . . .1046<br />
CareEvolve . . . . . . . . . . . . . . . . . . . . . . . . . .868<br />
Carolina Chemistries . . . . . . . . . . . . . . . .1910<br />
Carville Ltd . . . . . . . . . . . . . . . . . . . . . . . . .1767<br />
CCS Robotics . . . . . . . . . . . . . . . . . . . . . . . .869<br />
CellaVision . . . . . . . . . . . . . . . . . . . . . . . . . .959<br />
Cellestis, Inc. . . . . . . . . . . . . . . . . . . . . . . . .238<br />
Centerchem Inc. . . . . . . . . . . . . . . . . . . . .1845<br />
Centers <strong>for</strong> Disease Control<br />
& Prevention . . . . . . . . . . . . . . . . . . . . .4018<br />
Centers <strong>for</strong> Medicare &<br />
Medicaid Svcs . . . . . . . . . . . . . . . . . . . .9006<br />
Cepheid . . . . . . . . . . . . . . . . . . . . . . . . . . . .2715<br />
CERTEST BIOTEC s.l. . . . . . . . . . . . . . . . . .448<br />
Chembio Diagnostic Systems, Inc. . . . .160<br />
Chempaq Inc. .......................163<br />
Chemtron Biotech Inc. . . . . . . . . . . . . . .1867<br />
ChildLab . . . . . . . . . . . . . . . . . . . . . . . . . . .3713<br />
China Diagnostics Medical<br />
Corporation . . . . . . . . . . . . . . . . . . . . . .1265<br />
Chongqing Tianhai Medical<br />
Equipment Co. . . . . . . . . . . . . . . . . . . .3146<br />
CHROMSYSTEMS GmbH . . . . . . . . . . . .2442<br />
Chungdo Pharm. Co. Ltd. . . . . . . . . . . .1467<br />
CIS Biotech, Inc & Grace Laboratories 1864<br />
Cleveland Clinic Reference<br />
Laboratory . . . . . . . . . . . . . . . . . . . . . . . .564<br />
<strong>Clinical</strong> & Laboratory Standards Inst 9008<br />
<strong>Clinical</strong> Diagnostic Solutions, Inc. . . . .308<br />
<strong>Clinical</strong> Lab Products . . . . . . . . . . . . . . .3824<br />
CLINIQA Corporation . . . . . . . . . . . . . . . .312<br />
CMEF/IVD - China Int’l<br />
Med. Equip. Fair . . . . . . . . . . . . . . . . . .1354<br />
COLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3714<br />
College of <strong>American</strong> Pathologists . . .2215<br />
CompHealth . . . . . . . . . . . . . . . . . . . . . . .4012<br />
Comtron Corp. . . . . . . . . . . . . . . . . . . . . . .769<br />
Conductive Technologies Inc. . . . . . . .2157<br />
Cooper - Atkins Corporation . . . . . . . . .132<br />
Copan Diagnostics, Inc. . . . . . . . . . . . . . .220<br />
Corgenix . . . . . . . . . . . . . . . . . . . . . . . . . . .3529<br />
Coris Bioconcept . . . . . . . . . . . . . . . . . . .1224<br />
CORMAY S.A. . . . . . . . . . . . . . . . . . . . . . . .1267<br />
Creative Laboratory Products Inc. . . .4009<br />
Creatv Microtech . . . . . . . . . . . . . . . . . . .4016<br />
Critical Diagnostic . . . . . . . . . . . . . . . . . .3931<br />
Crony Instruments S.r.l. . . . . . . . . . . . . .1064<br />
Cryo Bio Systems . . . . . . . . . . . . . . . . . . . .669<br />
CSP Technologies, Inc. . . . . . . . . . . . . . .4047<br />
CTD Inc. & Beijing Bio Dev. Ltd. . . . . . .2368<br />
CTK Biotech, Inc. . . . . . . . . . . . . . . . . . . . .1263<br />
DA’AN GENE CO., LTD. . . . . . . . . . . . . . .1465<br />
Dartmouth Hitchcock<br />
Medical Center . . . . . . . . . . . . . . . . . . .3811<br />
DAS Srl . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1453<br />
Data Innovations, Inc. . . . . . . . . . . . . . . .2009<br />
David G. Rhoads Associates, Inc. . . . . .1030<br />
Dawning Technologies, Inc. . . . . . . . . .3830<br />
DENKA SEIKEN CO., LTD. . . . . . . . . . . . .3207<br />
DenLine Uni<strong>for</strong>ms, Inc. . . . . . . . . . . . . .3045<br />
Desert Biologicals/Omega Biologicals 202<br />
Dexter Magnetic Technologies, Inc. . .964<br />
DGP Group Ltd. . . . . . . . . . . . . . . . . . . . .2850<br />
diaDexus, Inc. . . . . . . . . . . . . . . . . . . . . . .4239<br />
Diagam . . . . . . . . . . . . . . . . . . . . . . . . . . . .1226<br />
Diagnostic Automation /<br />
Cortez Diagnostic ................3531<br />
Diagnostic Consulting Network . . . . .2252<br />
Diagnostic Laminations Engineering 209<br />
Diagnostica Stago, Inc. . . . . . . . . . . . . .3027<br />
DIALAB G.m.b.H. . . . . . . . . . . . . . . . . . . .1356<br />
Diamedix Corporation ..............2521<br />
Diametra SRL . . . . . . . . . . . . . . . . . . . . . .1668<br />
DiaMond Jordan . . . . . . . . . . . . . . . . . . .4148<br />
DiaSorin . . . . . . . . . . . . . . . . . . . . . . . . . . .2139<br />
DiaSys Diagnostic Systems GmbH . . .3417<br />
Diatron Messtechnik AMBH . . . . . . . . .1362<br />
Diazyme Laboratories . . . . . . . . . . . . . .2421<br />
DIBA Industries, Inc. . . . . . . . . . . . . . . . .1957<br />
DIESSE Diagnostica Senese S.p.A . . .3321<br />
Dirui Industrial Co., Ltd. .............1468<br />
DLD Diagnostika GmbH . . . . . . . . . . . .1861<br />
DNA Genotek Inc. . . . . . . . . . . . . . . . . . .4049<br />
DNA Vision . . . . . . . . . . . . . . . . . . . . . . . . .1228<br />
DOCRO, Inc. . . . . . . . . . . . . . . . . . . . . . . . .1753<br />
Double Q Lab . . . . . . . . . . . . . . . . . . . . . . .111<br />
Double-Dove Group Co., Ltd. . . . . . . .4142<br />
Dragon Medical (Shanghai) Ltd. . . . .3915<br />
Drew Scientific, Inc. . . . . . . . . . . . . . . . . .1930<br />
DRG International, Inc. ...............945<br />
Drucker Company, The . . . . . . . . . . . . . . .200<br />
Drummond Scientific . . . . . . . . . . . . . . .2625<br />
D-Tek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1230<br />
DXS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2414<br />
DYNEX Technologies Inc. . . . . . . . . . . .3111<br />
E2V Biosensors Ltd . . . . . . . . . . . . . . . . .2956<br />
EastCoast Bio, Inc. . . . . . . . . . . . . . . . . . .2063<br />
Egemin Automation Inc. . . . . . . . . . . . . .861<br />
EMD Chemicals, Inc. . . . . . . . . . . . . . . . .1953<br />
ENV Services Inc. . . . . . . . . . . . . . . . . . . .2846<br />
Epocal Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .264<br />
Eppendorf North America . . . . . . . . . .1431<br />
EQUITECH-BIO, Inc. . . . . . . . . . . . . . . . . .4143<br />
Erba Diagnostics Mannheim GmbH 2515<br />
Ercon Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .2949<br />
ESA Biosciences, Inc. . . . . . . . . . . . . . . . .3210<br />
Estapor/EMD Chemical . . . . . . . . . . . . .4243<br />
Eurogentec NA Inc. . . . . . . . . . . . . . . . . .4106<br />
Euroimmun AG . . . . . . . . . . . . . . . . . . . . .1061<br />
Eurotrol . . . . . . . . . . . . . . . . . . . . . . . . . . . .1902<br />
EVERGREEN SCIENTIFIC . . . . . . . . . . . . .4005<br />
Excel Scientific, Inc. . . . . . . . . . . . . . . . . .1866<br />
Express Diagnostics Inc. Int’l . . . . . . . . .110<br />
Fapon Biotech Inc. .................3717<br />
Ferrotec (USA) Corporation . . . . . . . . .1868<br />
Fertility Technology Resources, Inc. .3715<br />
Filtrona Fibertec . . . . . . . . . . . . . . . . . . . .1853<br />
Fine Care Biosystems . . . . . . . . . . . . . . .2946<br />
Fisher Healthcare . . . . . . . . . . . . . . . . . . .1911<br />
Fluid Metering, Inc. . . . . . . . . . . . . . . . . .2049<br />
Fluidigm Corporation . . . . . . . . . . . . . . .2052<br />
Focus Diagnostics . . . . . . . . . . . . . . . . . .2015<br />
Foliage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .565<br />
Fujirebio Diagnostics, Inc. . . . . . . . . . . .2727<br />
Furuno Electric Co., Ltd. . . . . . . . . . . . . .2943<br />
G&L Precision Die Cutting, Inc. . . . . . .2315<br />
Gale Force Software Corporation . . . .1958<br />
GE Healthcare . . . . . . . . . . . . . . . . . . . . . .2406<br />
Gema Medical, S.L. . . . . . . . . . . . . . . . . . .451<br />
Gems Sensors & Controls . . . . . . . . . . .2347<br />
GeneFluidics . . . . . . . . . . . . . . . . . . . . . . . .265<br />
Genisphere, Inc. . . . . . . . . . . . . . . . . . . . .1765<br />
Genius . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1464<br />
Gen-Probe . . . . . . . . . . . . . . . . . . . . . . . . .3019<br />
GenVault Corporation . . . . . . . . . . . . . .1663<br />
GenWay Biotech, Inc. . . . . . . . . . . . . . . .2256<br />
Genzyme Diagnostics . . . . . . . . . . . . . .1231<br />
Gerresheimer Wilden GmbH . . . . . . . .3411<br />
Globe Scientific Inc. . . . . . . . . . . . . . . . . .100<br />
GMI, INC. . . . . . . . . . . . . . . . . . . . . . . . . . . .2948<br />
GML . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2356<br />
Gold Standard Diagnostics Corp . . . .4129<br />
Golden West Biologicals, Inc. . . . . . . . . .145<br />
Greiner Bio-One, Inc. . . . . . . . . . . . . . . .3327<br />
Grifols Diagnostics-<br />
Diagnostic Division . . . . . . . . . . . . . .4025<br />
Haemoscope Corporation . . . . . . . . . .4022<br />
Hamilton Company . . . . . . . . . . . . . . . . .2043<br />
HandyLab, Inc. . . . . . . . . . . . . . . . . . . . . .1143<br />
Hanlab Corporation . . . . . . . . . . . . . . . .3906<br />
Hardy Diagnostics . . . . . . . . . . . . . . . . . . .128<br />
Harlan Bioproducts <strong>for</strong> Science . . . . .1659<br />
Haydon Switch & Instrument, Inc. . . .2053<br />
Health Care Logisitics . . . . . . . . . . . . . . .1167<br />
Helena Laboratories . . . . . . . . . . . . . . . . .556<br />
Helena Laboratories - POC . . . . . . . . . . .457<br />
HELMER . . . . . . . . . . . . . . . . . . . . . . . . . . . . .915<br />
Hemagen Diagnostics, Inc. . . . . . . . . .3310<br />
HemoCue Inc. . . . . . . . . . . . . . . . . . . . . . . .360<br />
Hemosure, Inc./WHPM, Inc. . . . . . . . . .4031<br />
Himedia Laboratories Pvt. Limited . . .2319<br />
HistoRx, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .969<br />
Hoover Precision Products, LLC . . . . .2154<br />
HORIBA ABX Diagnostics ...........1053<br />
HRA Research . . . . . . . . . . . . . . . . . . . . . . .309<br />
HTL - Strefa Inc. . . . . . . . . . . . . . . . . . . . .4147<br />
Hubit Co., Ltd. . . . . . . . . . . . . . . . . . . . . . .1469<br />
Human GmbH . . . . . . . . . . . . . . . . . . . . . .1656<br />
HyTest Ltd. . . . . . . . . . . . . . . . . . . . . . . . . .3802<br />
I.C.A. Corporation . . . . . . . . . . . . . . . . . . . .867<br />
IBL - America . . . . . . . . . . . . . . . . . . . . . . . .243<br />
IBL - Transatlantic Corp. . . . . . . . . . . . . . .106<br />
Idex Health & Science . . . . . . . . . . . . . . .1903<br />
IFCC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9001<br />
Illumina . . . . . . . . . . . . . . . . . . . . . . . . . . . .2711<br />
ILS Innovative Labor Systeme GmbH 864<br />
Imageinterpret GmbH . . . . . . . . . . . . . . .865<br />
IMMCO Diagnostics . . . . . . . . . . . . . . . .3905<br />
Immucor, Inc. . . . . . . . . . . . . . . . . . . . . . .2926<br />
Immunicon Corporation . . . . . . . . . . . .3807<br />
Immuno Concepts . . . . . . . . . . . . . . . . . .3705<br />
Immunodiagnostic Systems, Inc. . . . .2449<br />
IMPAC Medical Systems, Inc. . . . . . . . . .138<br />
InBios International, Inc. . . . . . . . . . . . . .114<br />
IND Diagnostic Inc. . . . . . . . . . . . . . . . . .1669<br />
Indiana Pathology Images . . . . . . . . . . .218<br />
Indicia Biotechnology . . . . . . . . . . . . . .2261<br />
2008 ANNUAL MEETING<br />
List of exhibitors
CliniCal laboratory news Special edition 19<br />
Infolab International Corporation . . .4041<br />
Innovacon Inc. . . . . . . . . . . . . . . . . . . . . .4013<br />
INOVA Diagnostics, Inc. . . . . . . . . . . . . . .551<br />
INSTRU-MED INC . . . . . . . . . . . . . . . . . . .3928<br />
Instrumentation Laboratory ........2703<br />
InTec Products, Inc. . . . . . . . . . . . . . . . . .2856<br />
Integrated DNA Technologies, Inc. . .1857<br />
Integrated Lab Automation<br />
Solution, Inc. . . . . . . . . . . . . . . . . . . . . .1647<br />
INTERBIOLAB, Inc. . . . . . . . . . . . . . . . . . .4004<br />
International Immuno-Diagnostics . .364<br />
International Immunology<br />
Corporation . . . . . . . . . . . . . . . . . . . . . .1526<br />
Inverness Medical Professional . . . . . .2439<br />
Invetech . . . . . . . . . . . . . . . . . . . . . . . . . . .1825<br />
Invitrogen . . . . . . . . . . . . . . . . . . . . . . . . . .965<br />
IQuum, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .1047<br />
IRIS Diagnostics . . . . . . . . . . . . . . . . . . . .2427<br />
i-SENS, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .1363<br />
Isensix, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .4226<br />
ITC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .531<br />
IVD Research, Inc. . . . . . . . . . . . . . . . . . . .104<br />
IVD Technologies . . . . . . . . . . . . . . . . . . .2264<br />
IVD Technology Magazine . . . . . . . . . .1665<br />
IVEK Corporation . . . . . . . . . . . . . . . . . . .2416<br />
Iwaki America Inc. . . . . . . . . . . . . . . . . . .1964<br />
Jackson ImmunoResearch<br />
Laboratories, Inc . . . . . . . . . . . . . . . . .2061<br />
JAJ International . . . . . . . . . . . . . . . . . . .4039<br />
Japan <strong>Association</strong> . . . . . . . . . . . . . . . . . .9005<br />
JAS Diagnostics, Inc. . . . . . . . . . . . . . . . .226<br />
JCAHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1944<br />
Jiangsu Kangjian Medical<br />
Apparatus Co. . . . . . . . . . . . . . . . . . . .2955<br />
JSR Corporation . . . . . . . . . . . . . . . . . . . .2854<br />
Kaiser Permanente . . . . . . . . . . . . . . . . .2751<br />
Kalorama In<strong>for</strong>mation . . . . . . . . . . . . . .3816<br />
Kamiya Biomedical Company . . . . . . .1839<br />
Kem-En-Tec Diagnostics . . . . . . . . . . . . .346<br />
KIKKOMAN CORPORATION . . . . . . . . . . .212<br />
Kinematic Automation Inc. . . . . . . . . . .851<br />
KMC Systems, Inc. . . . . . . . . . . . . . . . . . . .909<br />
KNF Neuberger Inc. ................3828<br />
KPL, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .2266<br />
KRONUS, Inc. . . . . . . . . . . . . . . . . . . . . . . .3231<br />
Lab Medica . . . . . . . . . . . . . . . . . . . . . . . .9004<br />
Labconco Corporation . . . . . . . . . . . . . .4117<br />
LabCorp-Esoterix . . . . . . . . . . . . . . . . . . .1153<br />
LabiTec GmbH, Germany . . . . . . . . . . . .1458<br />
Labnovation Technologies, Inc . . . . . . .121<br />
Labtest . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1352<br />
Lampire Biological Laboratories . . . . .3211<br />
LasX-Precision Medical<br />
Converting Group . . . . . . . . . . . . . . . .147<br />
Lathrop Engineering . . . . . . . . . . . . . . .1010<br />
Lattice Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .143<br />
Lee Company, The . . . . . . . . . . . . . . . . . .2747<br />
Lendell Manufacturing Inc. . . . . . . . . . .141<br />
Lifepoint In<strong>for</strong>matics . . . . . . . . . . . . . . .3806<br />
LifeScan Inc. . . . . . . . . . . . . . . . . . . . . . . .1539<br />
LifeSign LLC . . . . . . . . . . . . . . . . . . . . . . . . .266<br />
Lighthouse Recruiting . . . . . . . . . . . . . . .153<br />
Liofilchem S.R.L. . . . . . . . . . . . . . . . . . . .1561<br />
LipoScience, Inc. . . . . . . . . . . . . . . . . . . .1947<br />
LRE Medical, an Esterline Company 2909<br />
Lucigen Corporation . . . . . . . . . . . . . . .2066<br />
Luminex Corporation . . . . . . . . . . . . . . . .525<br />
LW Scientific . . . . . . . . . . . . . . . . . . . . . . .4245<br />
Lydall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3810<br />
m.u.t GmbH ........................3303<br />
Mack In<strong>for</strong>mation Systems . . . . . . . . . . .866<br />
Magellan Biosciences, Inc./<br />
Dynex Tech. . . . . . . . . . . . . . . . . . . . . .3115<br />
Magna Bio Sciences . . . . . . . . . . . . . . . . .305<br />
Magnasense Ltd. . . . . . . . . . . . . . . . . . . . .167<br />
Magnisense . . . . . . . . . . . . . . . . . . . . . . . .1353<br />
MagQu Co. . . . . . . . . . . . . . . . . . . . . . . . . .2855<br />
MagSense Life Sciences, Inc. . . . . . . . .3044<br />
Magsphere Inc. . . . . . . . . . . . . . . . . . . . . .1763<br />
Maine Biotechnology Services, Inc. . .1429<br />
Maine Standards Company . . . . . . . . .4242<br />
Man & Machine, Inc. . . . . . . . . . . . . . . . . .125<br />
Mayo Medical Laboratories . . . . . . . . .2627<br />
McKesson ..........................2343<br />
Mechatronics . . . . . . . . . . . . . . . . . . . . . .1443<br />
Med Travelers . . . . . . . . . . . . . . . . . . . . . .3814<br />
Medcompare . . . . . . . . . . . . . . . . . . . . . .3933<br />
Medica 2007/ Messe Duesseldorf . . .2060<br />
Medica Corporation . . . . . . . . . . . . . . . .2307<br />
Medical Automation Systems . . . . . . . .467<br />
Medical Courier Elite . . . . . . . . . . . . . . .2069<br />
Medical Device Consultants, Inc. . . . . .342<br />
Medical Device Safety Service GmbH 3932<br />
Medical Electronic Systems, LLC . . . .4113<br />
Medical Laboratory Evaluation(MLE) .2810<br />
Medical Staffing Network Inc. . . . . . .4119<br />
Medicon Hellas S A . . . . . . . . . . . . . . . . .1654<br />
MediFleet . . . . . . . . . . . . . . . . . . . . . . . . . .4246<br />
Medivative . . . . . . . . . . . . . . . . . . . . . . . . .4024<br />
Medix Biochemica . . . . . . . . . . . . . . . . . .3817<br />
MEDTOX Laboratories, Inc. . . . . . . . . . . .316<br />
Medtronic, Inc. . . . . . . . . . . . . . . . . . . . . . .461<br />
Melet Schloesing Laboratories . . . . . . .122<br />
Mercodia Inc. . . . . . . . . . . . . . . . . . . . . . .2950<br />
Meridian Life Science, Inc. . . . . . . . . . . .146<br />
Merlin Labs, Inc. ....................3818<br />
Metro Mold & Design, Inc. . . . . . . . . . .1764<br />
MGM Instruments, Inc. . . . . . . . . . . . . . .3229<br />
Michigan Diagnostics, LLC . . . . . . . . . . .108<br />
MICROLIT . . . . . . . . . . . . . . . . . . . . . . . . . .1366<br />
Microscan Systems, Inc. . . . . . . . . . . . . . .562<br />
Microsens Iseao . . . . . . . . . . . . . . . . . . . .3042<br />
Midland BioProducts Corp . . . . . . . . . .2718<br />
Millenia Diagnostics, Inc. . . . . . . . . . . . . .144<br />
Millipore Corporation . . . . . . . . . . . . . . . .415<br />
MiniFAB . . . . . . . . . . . . . . . . . . . . . . . . . . . .4144<br />
MiniGrip . . . . . . . . . . . . . . . . . . . . . . . . . . .4230<br />
Minitubes . . . . . . . . . . . . . . . . . . . . . . . . . .1652<br />
MiraVista Diagnostics/SSI Products . .2848<br />
Mitsubishi Chemical Medience<br />
Corporation . . . . . . . . . . . . . . . . . . . . . .2446<br />
MLO-Medical Laboratory Observer 3913<br />
MNX - Midnite Express<br />
Global Logistics . . . . . . . . . . . . . . . . . .4014<br />
Monobind Inc. . . . . . . . . . . . . . . . . . . . . .4216<br />
Moss, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .2724<br />
Motoman Inc. . . . . . . . . . . . . . . . . . . . . . .1161<br />
MP Biomedicals . . . . . . . . . . . . . . . . . . . .4208<br />
MT Promedt Consulting GmbH .....1369<br />
Multisorb Technologies, Inc. . . . . . . . .3611<br />
Nano-Ditech Corporation . . . . . . . . . . .2167<br />
NanoEntek . . . . . . . . . . . . . . . . . . . . . . . . .1067<br />
Nanogen, Inc. . . . . . . . . . . . . . . . . . . . . . .1547<br />
Nanosphere, Inc. . . . . . . . . . . . . . . . . . . .3324<br />
National Jewish Medical &<br />
Research Ctr. . . . . . . . . . . . . . . . . . . . . .216<br />
National Registry of<br />
Certified Chemists . . . . . . . . . . . . . . .3629<br />
Neogen Corporation . . . . . . . . . . . . . . . .1261<br />
New England Small Tube . . . . . . . . . . .2258<br />
NICHIREI BIOSCIENCES, INC. . . . . . . . .1360<br />
Nikon Instruments Inc. . . . . . . . . . . . . .3825<br />
NIST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4028<br />
NOF CORPORATION ................4146<br />
Norgren Inc. . . . . . . . . . . . . . . . . . . . . . . . .931<br />
Nor-Lake Scientific . . . . . . . . . . . . . . . . .2348<br />
Nova Biomedical . . . . . . . . . . . . . . . . . . .1927<br />
NOVO 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . .1809<br />
Novx Systems Inc. ..................3924<br />
NTE, S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . .553<br />
NuAire Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .939<br />
Olympus America, Inc. . . . . . . . . . . . . . . .225<br />
Omega Diagnostics Group PLC . . . . .1462<br />
OPERON S.A. . . . . . . . . . . . . . . . . . . . . . . . .460<br />
OPTI Medical System<br />
(Formely Osmetech) . . . . . . . . . . . . . . .363<br />
Opus Healthcare Solutions . . . . . . . . . . .566<br />
OraSure Technologies, Inc. . . . . . . . . . . .269<br />
Orchard Software Corp . . . . . . . . . . . . .3513<br />
Orphee S.A. . . . . . . . . . . . . . . . . . . . . . . . .1255<br />
Ortho-<strong>Clinical</strong> Diagnostics . . . . . . . . . .1525<br />
OSI Optoelectronics . . . . . . . . . . . . . . . .1766<br />
Osmetech Molecular Diagnostics . . .1002<br />
Owen Mum<strong>for</strong>d Inc. . . . . . . . . . . . . . . . . .165<br />
Oxonica Inc. . . . . . . . . . . . . . . . . . . . . . . . .3909<br />
Oyster Bay Pump Works, Inc. . . . . . . . . .250<br />
Pall Life Sciences . . . . . . . . . . . . . . . . . . .1752<br />
Panacea Pharmaceuticals, Inc. . . . . . . .127<br />
ParagonDx . . . . . . . . . . . . . . . . . . . . . . . . .3729<br />
Parker Hannifin/Pneutronics . . . . . . . .1968<br />
Parter Medical Products, Inc. . . . . . . . . .124<br />
Pathology Outlines.com, Inc. . . . . . . . . .767<br />
PBM-Princeton BioMeditech<br />
Corporation . . . . . . . . . . . . . . . . . . . . . .222<br />
PEAK-Service USA . . . . . . . . . . . . . . . . . . .913<br />
Peripheral Resources Inc. . . . . . . . . . . . .116<br />
PerkinElmer Life & Analytical<br />
Sciences . . . . . . . . . . . . . . . . . . . . . . . . . .953<br />
Perlong Medical Equipment<br />
Co., Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . .3054<br />
Phadia (Pharmacia Diagnostics) . . . . .1331<br />
Pharmigene, Inc. . . . . . . . . . . . . . . . . . . .4150<br />
Philosys ............................1367<br />
Phoenix Diagnostics Inc. . . . . . . . . . . . .4224<br />
Pointe Scientific, Inc. . . . . . . . . . . . . . . . .2726<br />
Polymedco, Inc. . . . . . . . . . . . . . . . . . . . .3314<br />
POLYMICROSPHERES . . . . . . . . . . . . . . .1761<br />
Precision Systems Inc. . . . . . . . . . . . . . .1542<br />
Prodesse, Inc. . . . . . . . . . . . . . . . . . . . . . . .131<br />
Proliant Health and Biologicals . . . . . . .151<br />
Promega Corporation . . . . . . . . . . . . . . . .663<br />
Propper MFG. Co., Inc. . . . . . . . . . . . . . .3711<br />
Psyche Systems Corporation . . . . . . . . .561<br />
Puritan Medical Products Company . .129<br />
PVT LabSystems . . . . . . . . . . . . . . . . . . . .3423<br />
Qarad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1666<br />
Qosina/Qosmedix . . . . . . . . . . . . . . . . . .2064<br />
Quad Five . . . . . . . . . . . . . . . . . . . . . . . . . . .105<br />
Quality Assured Services, Inc. . . . . . . .4127<br />
Quantimetrix Corporation . . . . . . . . . .2631<br />
Quantum Analytics . . . . . . . . . . . . . . . . . .862<br />
Quest Diagnostics . . . . . . . . . . . . . . . . . .1917<br />
Quidel Corporation . . . . . . . . . . . . . . . . .3105<br />
Quimica Clinica Aplicada, S.A. . . . . . . .449<br />
R&D Systems, Inc. ..................1016<br />
R2 Diagnostics . . . . . . . . . . . . . . . . . . . . .1906<br />
Radim SpA . . . . . . . . . . . . . . . . . . . . . . . . .1560<br />
Radiometer America Inc. . . . . . . . . . . .1939<br />
RAL, S.A. ............................352<br />
Randox Laboratories LTD . . . . . . . . . . .1407<br />
Rayto Life & Analytical<br />
Sciences Co, Ltd . . . . . . . . . . . . . . . . . . .242<br />
R-Biopharm AG . . . . . . . . . . . . . . . . . . . . .3510<br />
RD Plastics Company . . . . . . . . . . . . . . .2065<br />
Rees Scientific Corporation . . . . . . . . .3925<br />
Research Organics, Inc. . . . . . . . . . . . . .1961<br />
Response Biomedical Corp . . . . . . . . . . .369<br />
RNA Medical . . . . . . . . . . . . . . . . . . . . . . . .468<br />
RND Group, Inc., The . . . . . . . . . . . . . . . . .139<br />
Roche . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1007<br />
Roche Diagnostics - Point of Care . . .1223<br />
Rocky Mountain Diagnostics . . . . . . . .2847<br />
Rotek Industries . . . . . . . . . . . . . . . . . . . .3709<br />
RTEmd-Real Time Enterprises . . . . . . .2257<br />
SA Scientific LTD . . . . . . . . . . . . . . . . . . . .2360<br />
Safe-Tec <strong>Clinical</strong> Products, Inc. . . . . . .2068<br />
SAF-T-PAK . . . . . . . . . . . . . . . . . . . . . . . . .4248<br />
Sajar Plastics Inc. . . . . . . . . . . . . . . . . . . .1657<br />
Saladax Biomedical, Inc. . . . . . . . . . . . .4232<br />
Salimetrics, LLC . . . . . . . . . . . . . . . . . . . . .117<br />
Sarstedt, Inc. . . . . . . . . . . . . . . . . . . . . . . .2606<br />
Sartorius Stedim Biotech . . . . . . . . . . .2352<br />
Scantibodies Laboratory Inc. . . . . . . .1831<br />
SCC Soft Computer . . . . . . . . . . . . . . . . .2915<br />
SCETI K.K. . . . . . . . . . . . . . . . . . . . . . . . . .1566<br />
SciGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . .766<br />
SCIMEDX Corporation . . . . . . . . . . . . . .2410<br />
SCIPAC Ltd. . . . . . . . . . . . . . . . . . . . . . . . .1425<br />
Scripps Laboratories . . . . . . . . . . . . . . .2149<br />
SDI Biomed, Inc. . . . . . . . . . . . . . . . . . . . .1066<br />
Sebia Electrophoresis . . . . . . . . . . . . . . .3309<br />
Seegene, Inc. . . . . . . . . . . . . . . . . . . . . . . . .213<br />
Sekisui Medical Co., Ltd . . . . . . . . . . . . .3055<br />
Select Science . . . . . . . . . . . . . . . . . . . . .3144<br />
Sensor Electronic Technology, Inc. .2260<br />
SENTINEL CH SpA . . . . . . . . . . . . . . . . . .3722<br />
Sepmag Tecnologies . . . . . . . . . . . . . . . .452<br />
SeraCare Life Sciences . . . . . . . . . . . . . .2714<br />
Serion Immundiagnostica GmbH . . .3617<br />
Shanghai Kehua<br />
Bioengineering Co., Ltd. . . . . . . . . . .1762<br />
Shanghai Fosun Med-Tech<br />
Development .....................103<br />
Shanghai ZJ Bio-Tech Co., Ltd. . . . . . .1660<br />
Shenzhen Mindray . . . . . . . . . . . . . . . . . .825<br />
Sias AG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .667<br />
Siemens Healthcare Diagnostics . . . . .507<br />
Siemens Water Technologies . . . . . . . .1447<br />
Sifin GmbH . . . . . . . . . . . . . . . . . . . . . . . . .1552<br />
SimPort Plastics Ltd . . . . . . . . . . . . . . . . .3723<br />
Sinnowa Medical Science<br />
& Technology Co. . . . . . . . . . . . . . . . .1568<br />
SKC Co., Ltd.(Brand: INCYTO) . . . . . . . .4019<br />
SLR Research . . . . . . . . . . . . . . . . . . . . . . .2056<br />
SMC Corporation . . . . . . . . . . . . . . . . . . .2413<br />
SNIBE - Shenzhen New Industries . . .1559<br />
Softtech Health . . . . . . . . . . . . . . . . . . . .3917<br />
Source Scientific, LLC . . . . . . . . . . . . . . .2265<br />
Sou<strong>the</strong>rn Biotech . . . . . . . . . . . . . . . . . . .1758<br />
Span Diagnostics Limited . . . . . . . . . . . .157<br />
Spherotech Inc. . . . . . . . . . . . . . . . . . . . .2169<br />
Spinreact, S.A. . . . . . . . . . . . . . . . . . . . . . . .450<br />
Stanbio Laboratory . . . . . . . . . . . . . . . . .2615<br />
Standard Diagnostics, Inc. . . . . . . . . . .3328<br />
STRATEC Biomedical Systems AG . . . . .660<br />
Strategic Diagnostics Inc. . . . . . . . . . . .2163<br />
Streck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1938<br />
Sud-Chemie Per<strong>for</strong>mance Packaging 1253<br />
Super Brush LLC . . . . . . . . . . . . . . . . . . . .2362<br />
SurModics, Inc. . . . . . . . . . . . . . . . . . . . . . .246<br />
Swisslog . . . . . . . . . . . . . . . . . . . . . . . . . . .3930<br />
Synermed Select Partners, Inc. . . . . . .3827<br />
Syntron Bioresearch, Inc. . . . . . . . . . . . .1967<br />
Sysmex . . . . . . . . . . . . . . . . . . . . . . . . . . . . .639<br />
Taidoc Technology Corporation . . . . .3507<br />
Taigen Bioscience Corporation . . . . . . .567<br />
Tecan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .405<br />
Technidata /MediSolution . . . . . . . . . .3306<br />
Techno Medica Co. Ltd. . . . . . . . . . . . . . .763<br />
Teco Diagnostics . . . . . . . . . . . . . . . . . . .3624<br />
Tekra Corporation . . . . . . . . . . . . . . . . . . .256<br />
TELCOR, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .166<br />
Tetracore, Inc. . . . . . . . . . . . . . . . . . . . . . . .262<br />
Therapak Corporation . . . . . . . . . . . . . .3719<br />
Thermo Scientific . . . . . . . . . . . . . . . . . .2739<br />
Thin XXS Microtechnology AG . . . . . .2165<br />
Third Wave Technologies . . . . . . . . . . . .404<br />
TOKYO BOEKI MACHINERY LTD. . . . .1006<br />
Tosoh Bioscience, Inc. . . . . . . . . . . . . . .2403<br />
Toyobo Co., Ltd.<br />
c/o Shinko <strong>American</strong> Inc. . . . . . . . . .3813<br />
Trek Diagnostics Systems, Inc. . . . . . .3214<br />
TRINA BIOREACTIVES AG . . . . . . . . . . .3525<br />
Trinity Biotech . . . . . . . . . . . . . . . . . . . . .2105<br />
TTP Labtech . . . . . . . . . . . . . . . . . . . . . . . .1946<br />
Tyson Bioresearch, Inc. . . . . . . . . . . . . .1567<br />
UC San Francisco Medical Center . . . .966<br />
UNICO . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2166<br />
United Biotech, Inc. . . . . . . . . . . . . . . . .2269<br />
University of Virginia Health Systems 2450<br />
Urit Medical Electronic Co., Ltd . . . . . .3710<br />
UTAK Laboratories, Inc. . . . . . . . . . . . . .1544<br />
ValuMax International . . . . . . . . . . . . . .1829<br />
VEDALAB . . . . . . . . . . . . . . . . . . . . . . . . . .1865<br />
ViraCor Laboratories . . . . . . . . . . . . . . . .666<br />
Vircell S.L. . . . . . . . . . . . . . . . . . . . . . . . . . . .351<br />
ViroStat, Inc. . . . . . . . . . . . . . . . . . . . . . . . .149<br />
Visgeneer Inc. . . . . . . . . . . . . . . . . . . . . . .1569<br />
Vista Technology Inc. . . . . . . . . . . . . . . . .568<br />
VistaLab Technologies, Inc. . . . . . . . . .2248<br />
Vital Diagnostics . . . . . . . . . . . . . . . . . . .3403<br />
Vonco Products . . . . . . . . . . . . . . . . . . . . .119<br />
VR2M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1361<br />
VWR International . . . . . . . . . . . . . . . . . .1956<br />
W.B. Saunders/Mosby . . . . . . . . . . . . . .2811<br />
Wako Diagnostics . . . . . . . . . . . . . . . . . .1530<br />
Warde Medical Laboratory . . . . . . . . . . .962<br />
Waters Corporation . . . . . . . . . . . . . . . . .3820<br />
Web Industries Inc. . . . . . . . . . . . . . . . . .2263<br />
Welch Allyn, Inc. . . . . . . . . . . . . . . . . . . . .4228<br />
Wescor, Inc. . . . . . . . . . . . . . . . . . . . . . . . .3005<br />
WesTgard QC, Inc. . . . . . . . . . . . . . . . . . .1445<br />
Whatman Inc. . . . . . . . . . . . . . . . . . . . . . .3225<br />
Wheaton Science Packaging . . . . . . . .1952<br />
Wiener Laboratorios SAIC . . . . . . . . . .1452<br />
Wisepac Active Packaging<br />
Components Co. . . . . . . . . . . . . . . . . .3047<br />
Wondfo Biotech Co., Ltd. . . . . . . . . . . .1962<br />
Worthington Biochemical<br />
Corporation . . . . . . . . . . . . . . . . . . . . . .2161<br />
WSLH Proficiency Testing . . . . . . . . . . .2452<br />
Xceed Molecular . . . . . . . . . . . . . . . . . . .2155<br />
Xema-Medica Co., Ltd. . . . . . . . . . . . . . .1564<br />
Xiril . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3623<br />
YD Diagnostics . . . . . . . . . . . . . . . . . . . . .3630<br />
Yuhan NHS . . . . . . . . . . . . . . . . . . . . . . . . .1565<br />
Zebra Technologies . . . . . . . . . . . . . . . .4111<br />
Zentech . . . . . . . . . . . . . . . . . . . . . . . . . . . .1232<br />
ZeptoMetrix Corporation ...........2259<br />
Zeta Corporation . . . . . . . . . . . . . . . . . . .1924<br />
ZheJiang Gongdong Medical Plastic Fac-<br />
tor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .217<br />
ZheJiang U-Real Medical Tech. Co., Ltd. 107<br />
As of June 6, 2008
Low Resource Can Be High Quality<br />
Global healthcare, from page 1<br />
Organizing Committee, since she volunteered<br />
in Eritrea in 2006. She worked with<br />
a group of volunteers called Pathologists<br />
Overseas, who conduct training and help<br />
arrange <strong>for</strong> supplies and equipment to improve<br />
pathology and diagnostic services in<br />
developing countries. “I taught <strong>the</strong> medical<br />
students in <strong>the</strong>ir new medical school, and it<br />
really opened my eyes about global healthcare,”<br />
Gronowski said. “We don’t think<br />
about global healthcare, or everybody else’s<br />
health, on an everyday basis. We focus<br />
on our own little world. But to think that<br />
<strong>the</strong> health of people all around <strong>the</strong> world<br />
doesn’t affect us is like putting your head<br />
in <strong>the</strong> sand.” Gronowski is an Associate<br />
Professor of Pathology and Immunology,<br />
Obstetrics and Gynecology at Washington<br />
University School of Medicine in St. Louis.<br />
Gronowski spearheaded <strong>the</strong> ef<strong>for</strong>t to<br />
bring global health to <strong>the</strong> <strong>for</strong>efront of <strong>the</strong><br />
educational program this year, starting with<br />
<strong>the</strong> opening plenary by Roy Vagelos, MD,<br />
<strong>for</strong>mer CEO of Merck & Co., who played<br />
a key role in providing free drugs to treat<br />
river blindness in developing countries.<br />
Then on Tuesday morning, Mark Perkins,<br />
PhD, chief scientific officer of <strong>the</strong> Foundation<br />
<strong>for</strong> Innovative New Diagnostics<br />
(FIND) will delve into <strong>the</strong> technical needs<br />
<strong>for</strong> IVDs in developing countries. Later, a<br />
full-day symposium, “Challenges in Global<br />
Infectious Diseases,” will tackle emerging<br />
global health issues and what strategies<br />
governments and NGOs are using to build<br />
up laboratories in low-resource settings.<br />
Smaller is Better<br />
With funding from <strong>the</strong> Bill & Melinda<br />
Gates Foundation, Yager’s lab is leading a<br />
collaboration with <strong>the</strong> Stayton lab at <strong>the</strong><br />
University of Washington, PATH, Nanogen,<br />
and Micronics to develop a POC diagnostic<br />
plat<strong>for</strong>m <strong>for</strong> low-resource settings<br />
that can diagnose a wide range of diseases<br />
using parallel, nucleic acid-based assays,<br />
and immunoassays.<br />
The instrument, with an internal working<br />
name of <strong>the</strong> DxBox, features a compact,<br />
portable, shoe box-size reader, as well as<br />
disposable “lab cards” that use microfluidic<br />
circuits to per<strong>for</strong>m up to six different tests<br />
from a few drops of blood. Importantly,<br />
all of <strong>the</strong> necessary reagents and buffers<br />
will be in a <strong>for</strong>m that allows <strong>the</strong> cards to be<br />
stored <strong>for</strong> up to a year at ambient temperatures,<br />
and all sample cleanup and metering<br />
takes place within <strong>the</strong> card. “A capability<br />
that could not possibly have been extended<br />
to <strong>the</strong> developing world because of limitations<br />
of power, cost, reagent delivery, reagent<br />
storage, cold chain limitations, and<br />
transportation limitations—<strong>the</strong>se things<br />
are now possible,” said Yager. “We can really<br />
extend some of our most sophisticated<br />
mechanisms of diagnosing disease to <strong>the</strong><br />
remote ends of <strong>the</strong> diagnostic world. It’s<br />
not like we have to send <strong>the</strong> developing<br />
world our lowest quality, mediocre test—<br />
we can actually send <strong>the</strong>m some of <strong>the</strong> best<br />
tests. That’s pretty exciting, particularly on<br />
<strong>the</strong> nucleic acid side.” The initial panel of<br />
tests on <strong>the</strong> cards will diagnose rapid-onset<br />
fevers, such as malaria, dengue, measles,<br />
Rickettsia, and Salmonella.<br />
The DxBox tackles many of <strong>the</strong> problems<br />
inherent to low-resource testing: lack<br />
46 CliniCal laboratory news June 2008<br />
of reliable power, harsh environments, and<br />
a dearth of trained personnel available to<br />
draw blood, per<strong>for</strong>m testing, or maintain<br />
equipment. “Having been to Africa myself,<br />
you realize <strong>the</strong>y have way different<br />
needs than we do,” said Gronowski. “Both<br />
<strong>the</strong>ir instruments and <strong>the</strong>ir reagents are<br />
frequently exposed to huge fluctuations in<br />
temperature, or must endure a really sandy<br />
environment, or fluctuations in power<br />
supply—just extreme conditions. Also<br />
maintenance: when things break down in<br />
Eritrea, it’s days and days <strong>for</strong> a person <strong>the</strong>y<br />
have in Africa to get <strong>the</strong>re. So <strong>the</strong>se have to<br />
be reliable instruments, and <strong>the</strong>y have to be<br />
very easy to use. Moreover, quality control<br />
is often times not well understood, so <strong>the</strong>se<br />
need to be very stable instruments that are<br />
very <strong>for</strong>giving.”<br />
David Kelso, PhD, Associate Professor<br />
of Biomedical Engineering at Northwestern<br />
University, will moderate this afternoon’s<br />
“Diagnostics <strong>for</strong> <strong>the</strong> Developing<br />
World” session. He also stresses <strong>the</strong> need<br />
<strong>for</strong> simplicity. “The simpler you make <strong>the</strong><br />
device, <strong>the</strong> more complexity that is in it. It’s<br />
ei<strong>the</strong>r chemical complexity, or computer<br />
complexity, or mechanical complexity. You<br />
have to do something to make it simple to<br />
use,” said Kelso. “So a lot of times, that requires<br />
getting into new technologies that<br />
have never been applied to diagnostics in<br />
<strong>the</strong> developing world. You really have to<br />
push <strong>the</strong> technology a lot fur<strong>the</strong>r in <strong>the</strong>se<br />
settings than you do <strong>for</strong> <strong>the</strong> developed<br />
world.” Current rapid tests used in lowresource<br />
settings include lateral flow strips<br />
or immunochromatographic strips that<br />
are generally qualitative, can be stored <strong>for</strong><br />
long periods of time, and are relatively inexpensive.<br />
However, <strong>the</strong>se strips have not<br />
lived up to expectations, mainly due to user<br />
error. “What people have found is that <strong>the</strong><br />
per<strong>for</strong>mance of those tests is often not as<br />
good in developing world circumstances<br />
as <strong>the</strong>y are back in <strong>the</strong> labs,” said Yager. “So<br />
one of <strong>the</strong> things we’re attempting to do is<br />
minimize <strong>the</strong> amount of user intervention<br />
required, so that user variability is no longer<br />
a factor, and environmental variability<br />
is not as much of a factor as it would be<br />
o<strong>the</strong>rwise.”<br />
A Spectrum of Needs<br />
Kelso also emphasized ano<strong>the</strong>r factor in<br />
low-resource diagnostics: understanding<br />
<strong>the</strong> unique needs of each country or setting.<br />
“Really understanding what <strong>the</strong> customer<br />
requirements are is <strong>the</strong> top challenge<br />
in developing low-resource diagnostics, in<br />
<strong>the</strong> very broadest sense,” said Kelso. “We<br />
think a point-of-care test, taking it right<br />
out to primary care, would be <strong>the</strong> best solution.<br />
But you go out to those primary care<br />
developed by a collaboration of paul yager’s and patrick stayton’s<br />
labs at <strong>the</strong> university of Washington, along with paTh, nanogen, and<br />
Micronics, this shoe box-sized plat<strong>for</strong>m, called <strong>the</strong> dxbox, employs<br />
advanced microfluidic technology to offer reliable and low-cost testing<br />
<strong>for</strong> a wide range of diseases. The system uses credit-card sized, disposable<br />
‘lab cards’ that per<strong>for</strong>m up to six tests from a small patient sample<br />
<strong>for</strong> pocT in low-resource settings.<br />
sites, and a lot of times <strong>the</strong>re isn’t somebody<br />
<strong>the</strong>re that is certified to draw blood.<br />
So <strong>the</strong>n you follow <strong>the</strong> patient to when <strong>the</strong>y<br />
get tested, and it’s at a district hospital, and<br />
that’s not where we envisioned <strong>the</strong> test. So<br />
we’re trying to understand <strong>the</strong> structure of<br />
how care is delivered and what resources<br />
are in what locations.”<br />
Yager’s focus is on delivering POC tests<br />
in low-resource settings that can be used<br />
by anybody. “Clearly <strong>the</strong>re is a range of circumstances<br />
in <strong>the</strong> developing world. The<br />
cities often have nicely equipped hospitals<br />
and laboratories with power and most<br />
everything else <strong>the</strong>y need, but <strong>the</strong> issues<br />
you have tend to mostly be in remote<br />
areas, where you don’t have continuous<br />
power, where you may not have air conditioning,<br />
and where you probably don’t<br />
have highly-trained technicians and can’t<br />
get supplies in on a regular basis.” However,<br />
Yager noted that instruments such as <strong>the</strong><br />
DxBox can attend to needs across <strong>the</strong> spectrum.<br />
“The particular things that people<br />
want depends on <strong>the</strong> particular end user.<br />
Some of <strong>the</strong> people in <strong>the</strong> more sophisticated<br />
hospitals want quantitative results;<br />
<strong>the</strong> people in <strong>the</strong> lowest socioeconomic<br />
levels generally are looking at <strong>the</strong> quick<br />
and qualitative answer, like ‘Is it malaria or<br />
isn’t it?’ Not ‘How much malaria?’—just<br />
‘Which drug do I use to treat <strong>the</strong> patient as<br />
quickly as possible be<strong>for</strong>e <strong>the</strong>y go home?’<br />
Turnaround is a very big deal in all <strong>the</strong>se<br />
locations.”<br />
Coming Soon to a Clinic Near You?<br />
Although <strong>the</strong> DxBox and o<strong>the</strong>r POC instruments<br />
being developed <strong>for</strong> low-resource<br />
settings aim mainly to overcome<br />
environmental, economic, and personnel<br />
problems much different from those in<br />
U.S. labs, Kelso and o<strong>the</strong>rs stress that <strong>the</strong>se<br />
cutting-edge technologies will likely become<br />
very useful in developed countries<br />
in <strong>the</strong> near future as our healthcare system<br />
changes and evolves. “One trend that’s<br />
obvious is <strong>the</strong>se clinics that are starting to<br />
appear in Wal-Mart and all kinds of alternative<br />
sites,” said Kelso. “They are, in my<br />
mind, a lot like <strong>the</strong> walk-in clinics over in<br />
Africa. It’s not low-resource, but it’s a situation<br />
where it’s incredibly important to get<br />
<strong>the</strong> results of your diagnostic test while <strong>the</strong><br />
patient is right <strong>the</strong>re. There are lots of situations<br />
where having a rapid, point-of-care<br />
test improves <strong>the</strong> ability of <strong>the</strong> physician to<br />
treat <strong>the</strong> patient.”<br />
O<strong>the</strong>r potential uses of speedy and inexpensive<br />
low-resource methods include<br />
non-traditional healthcare settings like<br />
natural disasters, suggested Kelso, such as<br />
after a hurricane, when <strong>the</strong> usual laboratory<br />
infrastructure is wiped out. Mobile clinics<br />
or storefront clinics in impoverished areas<br />
could use <strong>the</strong>m as well. Yager also put <strong>for</strong>ward<br />
that hospitals might want something<br />
like his DxBox in certain circumstances.<br />
“Being able to have a rapid, nucleic acidbased<br />
test that can be done at <strong>the</strong> point-ofcare<br />
is really a critical capability. And if you<br />
do that, you don’t want <strong>the</strong> instrument to<br />
be incredibly expensive, because hospitals<br />
can’t af<strong>for</strong>d to put in a large number of<br />
extremely expensive instruments that duplicate<br />
capabilities in <strong>the</strong> centralized lab. So<br />
<strong>the</strong> development of <strong>the</strong>se technologies <strong>for</strong><br />
point-of-care use in <strong>the</strong> developing world<br />
enables <strong>the</strong> cost to be driven down far<br />
enough that you can bring <strong>the</strong> technology<br />
back to sites in <strong>the</strong> developed world.”<br />
Low-resource-type diagnostics might<br />
also someday become routine in developed<br />
countries who increasingly are seeking<br />
ways to care <strong>for</strong> poor and uninsured citizens.<br />
“Eventually our healthcare system is<br />
going to evolve to take care of <strong>the</strong> 40 million<br />
poorest people, and <strong>the</strong>y’re probably<br />
not going to be cared <strong>for</strong> in <strong>the</strong> same way<br />
that <strong>the</strong> richest 40 million are cared <strong>for</strong>,”<br />
noted Kelso. “So those clinics, those healthcare<br />
delivery systems are going to be different<br />
and will have functional aspects of <strong>the</strong><br />
way South Africans or Ugandans take care<br />
of <strong>the</strong>ir population.”<br />
Shifting to a Global Health Perspective<br />
Although global healthcare doesn’t always<br />
mean low-resource healthcare, it does represent<br />
a different world view when it comes<br />
to laboratory medicine. “I would challenge<br />
people to think about more than just <strong>the</strong>mselves<br />
in what <strong>the</strong>y perceive as <strong>the</strong>ir immediate<br />
patient base,” said Gronowski. “We in<br />
healthcare have to take responsibility <strong>for</strong><br />
<strong>the</strong> health of <strong>the</strong> world. In <strong>the</strong> long run, I<br />
believe it will affect <strong>the</strong> people in your small<br />
circle. If <strong>the</strong> health of people worldwide is<br />
good, <strong>the</strong>n I don’t have to worry about<br />
Ebola virus, and bird flu, and SARS. I think<br />
we have to be knowledgeable about global<br />
health so that we can perhaps help o<strong>the</strong>rs,<br />
but <strong>the</strong>n ultimately down <strong>the</strong> road, to help<br />
ourselves as well.” cln
industry Workshops, continued from p. 6<br />
Wednesday, july 30<br />
7:00 a.m.–8:30 a.m.<br />
DENKA SEIKEN Co., Ltd.<br />
Small, Dense LDL Cholesterol and Heart<br />
Disease Prediction: Results from Framingham<br />
Speaker: Ernst J. Schaefer, MD, Professor and<br />
Senior Scientist, Tufts University School of<br />
Medicine<br />
Grand Hyatt Washington, Independence B<br />
Diagnostic Consulting Network<br />
Application of Fluorescence in Next<br />
Generation Lateral Flow Assays<br />
Speakers: Brendan O’Farrell, PhD, President,<br />
Diagnostic Consulting Network<br />
Jeff Bauer, Executive Vice President, R&D,<br />
Diagnostic Consulting Network<br />
Renaissance Hotel, Meeting Room 12, 13<br />
Roche<br />
Prepare <strong>for</strong> <strong>the</strong> Changes in Hepatitis C<br />
Speakers: Brigitte Fernandes-McAlear, MBA,<br />
Group Marketing Manager, Roche Diagnostics<br />
Corporation<br />
Bryan Cobb, PhD, FACMG, Manager<br />
<strong>Clinical</strong> and Scientific Affairs, Roche<br />
Diagnostics Corporation<br />
Steve Rossi, PharmD, Roche Molecular<br />
Diagnostics<br />
Renaissance Hotel, Meeting Room 16<br />
Roche/OraSure<br />
The Value of Oral Fluid Testing<br />
Speakers: Edward J. Cone, PhD,<br />
Penney Associates, Scientific Advisor<br />
R. Sam Niedbala, PhD, Lehigh University,<br />
Professor, Department of Chemistry<br />
Grand Hyatt Washington, Constitution B<br />
Roche<br />
Vitamin D 101: <strong>Clinical</strong> Utility of Monitoring<br />
Vitamin D3 in <strong>the</strong> General Public<br />
Speakers: Robert P. Heaney, MD, FACP,<br />
FACN, John A. Creighton University, Professor<br />
of Medicine, Department of Medicine.<br />
TBD<br />
Grand Hyatt Washington, Constitution A<br />
Roche<br />
Maximizing <strong>the</strong> Effectiveness of Your<br />
Intraoperative PTH program: Interpreting <strong>the</strong><br />
New NACB Guidelines—The Lab and<br />
<strong>the</strong> Surgeon Perspective<br />
Speakers: Lori J. Sokoll, PhD, FASB,<br />
John Hopkins Medical Institutions,<br />
Associate Director of <strong>Clinical</strong> Chemistry,<br />
Department of Pathology<br />
Robert Udelsman, MD, MBA, FACS,<br />
William H. Carmalt Professor of Surgery,<br />
Chairman of Surgery, Chief, Surgery,<br />
Yale-New Haven Hospital<br />
Grand Hyatt Washington, Constitution D, E<br />
Sebia Electrophoresis<br />
The Diagnosis of Hemoglobinopathies and<br />
Thalassemias Utilizing Capillary Zone<br />
Electrophoresis Technology: Case Studies and<br />
Comparisons to Traditional Methodologies<br />
Speakers: Edward Wong, MD, Director of<br />
Hematology, Associate Director of Transfusion<br />
Medicine, Children’s Nation Medical Center<br />
Aigars Brants, PhD, Scientific Affairs Manager,<br />
Sebia Electrophoresis<br />
Grand Hyatt Washington, Farragut Square<br />
Siemens Healthcare Diagnostics<br />
High Sensitivity Troponin—Delivering<br />
Value <strong>for</strong> Chest Pain Management<br />
Speaker: Theresa Spence, Siemens Healthcare<br />
Diagnostics<br />
Grand Hyatt Washington, Independence F<br />
Siemens Healthcare Diagnostics<br />
Trends in Immunosuppressive Drug Use and<br />
Cost-Effective Monitoring of Immunosuppressive<br />
Drugs at <strong>the</strong> Local Community Level<br />
Speaker: Kelli Ryzewski,<br />
Siemens Healthcare Diagnostics<br />
Grand Hyatt Washington, Independence H<br />
Sysmex America, Inc.<br />
Sysmex XT-V Multi-Species<br />
Hematology Analyzer<br />
Speakers: Andrew R. Hay, Senior Director,<br />
Health System Sales, Sysmex America, Inc.<br />
Susan A. Vuylsteke, MD, Account Executive,<br />
Comparative Hematology, Sysmex America,<br />
Renaissance Hotel, Congressional Hall A<br />
Whatman, Inc.<br />
Blood Separation <strong>for</strong> Rapid Diagnostics:<br />
Principles, Materials, and Practice<br />
Speaker: Vincent A. Sy, Whatman, Inc.,<br />
Technical Marketing, Manager<br />
Grand Hyatt Washington, Constitution C<br />
6:00 p.m.–7:30 p.m.<br />
Applied Biosystems<br />
Advances in <strong>the</strong> use of LC/MS/MS<br />
<strong>for</strong> Toxicology Analysis<br />
Speakers: TBD<br />
Grand Hyatt Washington,<br />
Independence G, H, I<br />
Dawning Technologies, Inc.<br />
Advanced Applications of<br />
Dawning Middleware<br />
Speakers: John Selmyer, President, Dawning<br />
Technologies, Inc.<br />
Greg Schallert, Engineering Manager, Dawning<br />
Technologies, Inc.<br />
Grand Hyatt Washington,<br />
Constitution C & Corridor C<br />
Luminex<br />
Enhanced Detection of Respiratory Viruses<br />
Using <strong>the</strong> Luminex xTAG RVP Assay<br />
Speaker: Dr. Christine Ginocchio, Director<br />
of Microbiology and Molecular Diagnostics,<br />
Northshore Long Island Jewish Hospital<br />
Renaissance Hotel, Grand Ballroom East<br />
Ortho-<strong>Clinical</strong> Diagnostics, co-sponsored by<br />
bioMérieux and Roche Diagnostics<br />
Clarifying <strong>the</strong> Role of<br />
NT-proBNP by Consenus<br />
Speakers: TBD<br />
Renaissance Hotel, Grand Ballroom South<br />
Osmetech Molecular Diagnostics<br />
Latest Developments in <strong>the</strong><br />
Pharmacogenetics of Warfarin<br />
Speaker: Michael D. Caldwell, MD, PhD,<br />
FACS, Marshfield Clinic<br />
Grand Hyatt Washington, Constitution B<br />
Randox Laboratories Ltd.<br />
Biochips Can Save Lives—Cardiovascular<br />
and Cerebrovascular Disease<br />
Speakers: Dr. Peter Fitzgerald, Managing<br />
Director, Randox Laboratories Ltd.<br />
John Lamont, Chief Scientific Officer,<br />
Randox Laboratories Ltd.<br />
Renaissance Hotel, Congressional Hall A<br />
Roche<br />
Scott and White HAI Control<br />
and Screening Program<br />
Speaker: Arundhati Rao, MD, Section Chief,<br />
Technical Pathology and Molecular Genetics,<br />
Scott and White Hospital<br />
Grand Hyatt Washington, Independence D, E<br />
Siemens Healthcare Diagnostics<br />
Non-Invasive Markers of Liver Fibrosis—Why<br />
Are They Needed?<br />
Speaker: Andrew Beard, Siemens Healthcare<br />
Diagnostics<br />
Renaissance Hotel, Ballroom West A<br />
Siemens Healthcare Diagnostics<br />
The A, B, and C’s of In Vitro Allergy Testing<br />
Speakers: TBD<br />
Renaissance Hotel, Ballroom West B<br />
Siemens Healthcare Diagnostics<br />
Trends in Infectious Disease Testing:<br />
A Conversion of Technologies to<br />
Meet <strong>the</strong> Emerging Threat<br />
Speakers: Ka<strong>the</strong>rine Soreng,<br />
Siemens Healthcare Diagnostics<br />
Grand Hyatt Washington, Independence B<br />
Thermo Fisher Scientific<br />
From Biomarker Discovery to Routine<br />
Assay-LCMS in <strong>Clinical</strong> Research Laboratories<br />
Speakers: Dr. Mary Lopez, Director,<br />
Biomarker Discovery Institute<br />
Dr. Ravinder Singh, Director, Endocrinology<br />
Laboratory, Mayo Clinic<br />
Dr. Donald Chace, Laboratory Director,<br />
Pediatric Medical Group<br />
Grand Hyatt Washington, Constitution D, E<br />
Third Wave Technologies<br />
Third Wave’s HPV <strong>Clinical</strong> Trial Results<br />
Speakers: TBD<br />
Renaissance Hotel, Grand Ballroom South<br />
As of May 14, 2008<br />
index To adverTisers<br />
please thank <strong>the</strong>se advertisers by telling <strong>the</strong>m you saw <strong>the</strong>ir<br />
advertisement in <strong>Clinical</strong> Laboratory News.<br />
3M Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7<br />
AutoGenomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33<br />
Bio-Rad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11<br />
Chromsystems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2<br />
College of <strong>American</strong> Pathologists . . . . . . . . . . . . . . . . . . . . . . . 27<br />
Fluid Metering (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37<br />
Gerresheimer Wilden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41<br />
Hoover Precision Prods (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . 43<br />
Instrumentation Laboratory ............................. 40<br />
Lifescan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13<br />
Midland BioProducts (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41<br />
Mindray ................................................ 15<br />
Olympus America ...................................24 & 25<br />
Ortho-<strong>Clinical</strong> Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17<br />
Proliant Health & Biologicals ............................. 34<br />
Randox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35<br />
Roche Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 & 5, 21, 29<br />
Siemens Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48<br />
Sysmex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />
Tosoh Bioscience ........................................ 31<br />
Wheaton Science Pkg (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39<br />
��������������������<br />
���������������������<br />
����������<br />
���������<br />
�����������������<br />
new Titles from<br />
aacc press<br />
Visit <strong>the</strong> AACC Bookstore to see <strong>the</strong><br />
latest releases from AACC Press.<br />
dna from a to Z & back again<br />
Carol A. Holland and Daniel H. Farkas<br />
2008, 191 pages, softcover<br />
ISBN 9781594250880<br />
Product #5104<br />
handbook of diagnostic<br />
endocrinology, second edition<br />
Edited by William E. Winter,<br />
Lori J. Sokoll, and Ishwarlal Jialal<br />
2008, 447 pages, softcover<br />
ISBN 9781594250866<br />
Product #5105<br />
self-assessment in<br />
clinical laboratory science ii<br />
Edited by Alan H.B. Wu<br />
2008, 382 pages, softcover<br />
ISBN 9781594250873<br />
Product #5106<br />
Quick Guide to clinical chemistry<br />
Q U I C K G U I D E T O<br />
<strong>Clinical</strong><br />
Janelle M. Chiasera, Robert W. Chemistry Hardy,<br />
Janelle M. Chiasera<br />
Robert W. Hardy<br />
John A. Smith<br />
and John The Quick Guide to <strong>Clinical</strong> A. Chemistry Smith<br />
is a pocket-sized<br />
reference intended <strong>for</strong> physicians, nurses, physician<br />
assistants, nurse practitioners, medical technologists,<br />
pharmacists, and residents and students in those professions.<br />
This guide focuses on <strong>the</strong> selection and use of chemistry<br />
laboratory tests <strong>for</strong> diagnosing and managing emergent<br />
conditions such as poisonings, acute abdominal pain, and<br />
acute myocardial infarction.<br />
2008, 92 pages, softcover<br />
The guide's small size allows it to be used in situations when<br />
quick decisions must be made regarding <strong>the</strong> ordering and<br />
interpretation of chemistry tests. The emergent clinical<br />
conditions and <strong>the</strong> associated laboratory tests are described<br />
toge<strong>the</strong>r <strong>for</strong> quick reference.<br />
Although this Guide reviews several clinical conditions, it is<br />
not intended to be a comprehensive guide to all clinical<br />
ISBN 9781594250729<br />
laboratory tests, nor is it intended to dictate what constitutes<br />
reasonable, appropriate, or best care in a given situation.<br />
Comprehensive<br />
references <strong>for</strong> such<br />
in<strong>for</strong>mation currently<br />
exist. Instead, it should be<br />
seen as it is clearly<br />
named, a “Quick Guide”<br />
Product #4631<br />
to clinical chemistry.<br />
HANDBOOK OF<br />
DIAGNOSTIC<br />
ENDOCRINOLOGY<br />
after <strong>the</strong> show—Two easy Ways to order<br />
Online: www.aacc.org<br />
Phone: Call AACC (1(800) 892-1400 and place your order directly with an<br />
AACC customer service representative. Have your credit card ready.<br />
coming soon…<br />
Applying Evidence-Based Laboratory Medicine: A Step-by-Step Guide<br />
Christopher P. Price and Robert H. Christenson<br />
Brain Biomarkers <strong>for</strong> Cerebral Ischemia: NMDA Neuroreceptors Degradation and Blood<br />
Assay Development, Svetlana Dambinova<br />
Handbook of Workplace Drug Testing, Second Edition<br />
edited by Jeri D. Ropero-Miller and Bruce A. Goldberger<br />
SECOND EDITION<br />
CliniCal laboratory news June 2008 47<br />
EDITED BY<br />
WILLIAM E. WINTER,<br />
LORI J. SOKOLL,<br />
ISHWARLAL JIALAL,<br />
Q U I C K G U I D E T O<br />
ELECTROLYTES<br />
ASPARTATE AMINOTRANSFERASE<br />
ALANINE AMINOTRANSFERASE<br />
GAMMA-GLUTAMYL <strong>Clinical</strong><br />
TRANSFERASE<br />
LIPASE<br />
GASTRINChemistry<br />
ACETAMINOPHEN<br />
CREATINE KINASE<br />
BRAIN NATRIURETIC PEPTIDE<br />
TROPONINS<br />
BLOOD UREA NITROGEN<br />
CREATININE<br />
OSMOLALITY<br />
CORTISOL<br />
BLOOD GASES<br />
GLUCOSE<br />
ANION GAP<br />
BILIRUBIN<br />
AMMONIA<br />
THERAPEUTIC DRUG MONITORING<br />
PHOSPHATIDYLGLYCEROL<br />
Janelle M. Chiasera<br />
FETAL FIBRONECTIN<br />
Robert W. Hardy<br />
John A. Smith<br />
THYROID STIMULATING HORMONE<br />
THYROID ANTIBODIES